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AFIT/GCA/ENV/09-M02 
Abstract 
 The primary purpose of this research was to improve the effectiveness of cost 
comparison analyses for the 75th Aerospace Medicine Group, Hill Air Force Base, Utah.  
Bioenvironmental engineers sought a more robust cost comparison tool, allowing 
engineers to quickly determine the viability of proposed occupational health-related 
expenditures. To justify the funding of potential projects, engineers must quantify the 
expected cost savings.  Improved cost comparison analysis enables personnel to better 
justify worthy projects or filter out uneconomical solutions. 
 A secondary purpose of this research was to validate Department of Defense 
(DoD) occupational illness cost factors.  This research effort focused on cost factors for 
illnesses resulting in no lost work time and for illness resulting in hospitalization.  The 
existing cost factors were developed in 1988, and no continuity or existing methodology 
is available to determine how the factors were developed.  We modeled direct medical 
expenditures related to occupational illness for a specific set of illnesses for active duty 
Air Force personnel to validate the “no lost time” factor.  Additionally, we attempted to 
validate and apportion the hospitalization factor into direct and indirect occupational 
illness costs.  This new knowledge will allow leaders to plan for and mitigate potential 
occupational illness costs.  
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MODELING U.S. AIR FORCE OCCUPATIONAL HEALTH COSTS  
I.  Introduction 
 
Background 
“Lack of evidence on cost-effectiveness is likely to be regarded as the same as 
activities demonstrated not to be cost-effective” (Miller, Rossiter, & Nuttall, 2002: 477).  
The preceding quotation states the overarching problem to improving occupational health 
processes.  If cost estimating models cannot deliver reliable and defendable results, one 
should not expect investments to be made.  This holds true in most instances, to include 
occupational health. 
Convincing leaders to invest scarce resources on support functions is challenging, 
and rightly so.  In a sense, commanders are fiduciaries to the taxpayers and must 
responsibly spend appropriated funds.  While safety and occupational health 
requirements will likely rank high on any commander’s priority list, such requirements 
seldom receive enough attention and justification to warrant funding. 
 Bioenvironmental engineers (BEEs) are tasked with ensuring occupational health 
requirements receive necessary attention.  The 75th Aerospace Medicine Squadron, 
Bioenvironmental Engineering Flight at Hill Air Force Base, Utah (75 AMDS/SGPB) is a 
good example of a real-world operational unit that spends a considerable amount of time 
analyzing potential occupational health risks and initiatives for improvements.  BEEs 
ensure workers are not exposed to dangerous workplace conditions.  They advocate for 
process improvement or material substitutions that help mitigate potential hazards.  While 
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BEEs often link tangible benefits such as cost or personnel savings to process changes, 
they also must consider the indirect costs associated with their recommendations.  
 The direct costs associated with the aforementioned initiatives are usually 
quantifiable.  Direct costs of occupational illnesses include medical bills, insurance 
compensation, and other costs directly attributable to an occupational illness.  Direct 
benefits also include savings of time, money, materials or any combination of the three.  
Capturing indirect costs is much more difficult.  Occupational illness costs are 
synonymous to an iceberg floating in the water.  See Figure 1 for an example, modeled 
after WSES.biz, 1992.  The smaller direct costs, represented by the portion of the iceberg 
above the water, are visible and easier to tally.  The disproportionately larger indirect 
costs, hidden below the water in the proverbial iceberg, have been estimated as high as $6 
to $53 for each $1 of direct cost (Bird & Germain, 1996: 8).  These indirect costs include 
employee turnover, lower morale, lost production, lost time wages, administrative 
burden, lost sales, and lost reputation/goodwill (Basu & Wright, 2005).   
Figure 1. Total Cost of Illness “Iceberg”  
 
 
 
 
 
 
$5 to $50 Ledger Costs for: 
Building/Tool Damage 
Equipment Damage 
Legal Expenses 
Emergency/Interim Supplies 
 
$1 to $3 Uninsured Costs for: 
Investigations 
Lost Productivity  
Turnover 
Lost Wages 
Lost Goodwill 
 
$1 Direct Costs for: 
Medical Bills 
Insured Costs 
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 
$1 
$6 to $53 
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 Illnesses are much more complicated to quantify than injuries.  To differentiate, 
occupational injuries are readily attributable to a specific time, place and cause.  Injuries 
are a result of “rapid, uncontrolled transfer of energy (chemical, electromagnetic, 
electrical, thermal, and mechanical) to an individual resulting in loss” (Slagley, 2008).  
Illnesses, on the other hand, are usually the result of repeated exposure to an adverse 
physical or chemical factor in the workplace.   
The exact dollar figure for indirect illness costs is difficult to quantify for several 
reasons.  As previously noted, occupational illnesses generally happen as a result of long-
term exposure to a hazard.  A patient may no longer be employed at the organization 
where the exposure occurred when he or she becomes ill.  Doctors may not attribute the 
illness to an occupation, resulting in an under reporting of occupational illness and the 
associated cost.  Occupational illnesses are difficult to link to specific causes.  Illnesses 
could result from a multitude of factors, such as genetic disposition to disease, previous 
exposure, certain combinations of exposures, and general health of an individual.  
Finally, the severity and duration of illness are major factors in determining indirect 
costs.  Illnesses lasting longer or causing more pain, suffering, and disability will be more 
expensive, simply based on the need for more medicine, longer hospitalizations, and 
higher percentages of worker’s compensation. 
Problem Statement 
 Bioenvironmental engineers seek a robust, transparent, and defendable tool to 
capture and articulate potential cost savings associated with occupational health 
expenditures, convincing decision makers that investing scarce resources in occupational 
health matters can be a highly effective use of funds.  Engineers can accomplish this task 
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by changing the way decision makers think in terms of cost-effectiveness.  While initial 
capital costs may be much less for one alternative, the “cheaper” option with lower start-
up costs may end up being the more expensive course of action in the long run.  We will 
demonstrate how the entire life cycle costs must be considered before determining which 
alternative is best.  The engineers are currently experiencing some difficulty accurately 
quantifying costs of potential occupational health projects.   
The existing methodology compares the cost of a new process, such as new 
equipment, training, or manpower with the expected benefits, such as reduced 
materials/time/personnel.  However, the existing methodology ignores the time value of 
money because engineers compare the initial cost of a new process with the cost of the 
current process.  Some new processes may initially require a capital investment, making 
the project seem more expensive than it really is.  The existing methodology does not 
allow engineers to accurately compare alternatives using concepts such as equivalent 
annual cost, breakeven analysis, or sensitivity analysis. 
In addition to making the cost comparisons more accurate, bioenvironmental 
engineers must be able to determine the total cost of occupational illness.  Total cost is 
determined by combining direct and indirect costs.  Cost analysts need to apportion the 
DoD hospitalization cost factor into direct and indirect cost components.  If analysts are 
able to apportion the costs, follow-on research and modeling efforts may allow engineers 
to use this information to further improve project justifications. 
Research Objectives 
Research Questions. 
 What is the most effective cost comparison methodology to use? 
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Is the DoD cost factor for occupational illness resulting in no lost time a reliable 
estimate for medical costs? 
 
Can the DoD total cost factor for occupational illness resulting in hospitalization 
be separated into direct and indirect costs? 
  
Hypothesis. 
1. Using equivalent annual cost methodology when performing cost comparison 
analyses may result in choosing alternatives which were previously believed 
to be too expensive. 
 
2. DoD cost factor for occupational illness resulting in no lost time is reliable. 
 
3.   DoD cost factor for occupational illness resulting in hospitalization is reliable.  
 
Research Focus 
 The initial area of research focuses on determining the most effective cost 
comparison tool for situations typically encountered by bioenvironmental engineers from 
the 75th Aerospace Medicine Squadron at Hill Air Force Base, Utah.  The end product 
will include a software-based user interface, such as a Microsoft Excel® spreadsheet, to 
facilitate analyses.   
 Additionally, research efforts will seek to validate existing DoD occupational 
illness cost factors.  The DoD cost factor for no lost time estimates the direct medical 
expenses resulting from ambulatory visits for occupational illnesses.  The cost factor for 
hospitalization supposedly estimates total cost, to include both direct and indirect 
occupational illness costs for hospitalization of occupational illnesses.  According to DoD 
Instruction 6055.07, Accident Investigation, Reporting, and Record Keeping, the total 
costs include pay while away from work, medical treatment, hospitalization, dependent 
survival, training costs, burial, compensation, and disability retirement (DoD: 2008).  We 
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theorize the total costs are extremely elusive to capture, based on research of existing 
attempts at estimating indirect cost.  We will use direct medical costs for Active Duty Air 
Force personnel from FY1999 to FY2008 for a specific set of 74 illnesses to model direct 
and indirect cost factors.  We will then compare our new factors with DoD’s attempt in 
1988 to estimate illness costs. 
Assumptions 
 Several assumptions must be made to facilitate the research efforts.  To start, the 
author will develop a cost comparison methodology generic enough to cover foreseeable 
situations at an Air Logistics Center, such as Hill Air Force Base.  The methodology will 
allow comparison of alternatives with equal project lives and allow users to vary inputs 
and see the resulting impact via a graphical display. 
The methodology will also incorporate time value of money.  Time value of 
money is normally associated with commercial endeavors when the interest rate, or cost 
of borrowing capital, and the discount rate, or expected return on capital, greatly affect 
the decision outcome.  A dollar spent today has a different value than a dollar spent 10 
years from now.  While Air Force expenditures are not normally affected by interest rates 
from a “business” point of view, decision makers should consider discount rates and time 
value of money because some alternatives may require a significant outlay of capital in 
the short term.  An appropriate discount rate will determine if the capital-intensive 
alternative is worth the risk.   
When considering a discount rate in the final model, there are limitations of 
accuracy in estimating these rates.  The Office of Management and Budget (OMB) 
recommends using a 7% internal rate of return (OMB Circular A-94).  A single discount 
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rate may simplify calculations for the end user instead of determining a variable rate 
based on the length of project.  We do not feel setting the discount rate at 7% 
compromises the final model.  If a sensitivity analysis of several alternatives results in 
changing in a decision based on the discount rate fluctuation, we feel other tangible 
factors will take precedence in the decision process.   
Implications 
 The cost comparison tool could have potential service-wide implications.  Many 
decisions makers throughout the Air Force, whether they are bioenvironmental engineers, 
civil engineers, logisticians, or front-line managers, may not have the time or tools 
necessary to accurately compare alternatives when allocating budgets.  The end product 
of this research effort will allow decision makers to have more accurate information.  
With more accurate information, we anticipate better decisions, ultimately resulting in 
more effective use of taxpayer dollars. 
 A new understanding of how to reduce medical costs may increase occupational 
health expenditures.  As a result, occupational health expenditures may lead to safer 
working environments through reduced occurrences of occupational illness.  According 
to the Air Force Operational Risk Management (ORM) website, “ORM is a decision-
making process to systematically evaluate possible courses of action, identify risks and 
benefits, and determine the best course of action for any given situation” (ORM 
University, 2008).  Decision makers could lower overall costs and improve ORM, 
creating a win-win situation for everyone. 
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Preview 
  Discussion will begin with existing literature on the topic of occupational illness, 
as well as attempts to capture costs through various methods.  The author will develop a 
cost comparison tool to meet the customers’ needs, allowing comparison of multiple 
options across a range of user input criteria.  The author will then develop a regression 
model to validate DoD cost factors, based on the amount of direct medical costs.  Finally, 
the author will discuss the applicability for service-wide use, as well as submit 
recommendations to improve analyzing occupational illness costs in the future. 
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II. Literature Review 
 Most pertinent literature regarding occupational illness modeling stems from 
ground-breaking efforts by Dr. Paul Leigh.  His team performed the most complete effort 
to date of estimating direct and indirect costs.  Additionally, Dr. Katharyn Grant 
published a cost/benefit analysis handbook targeted to Environmental, Safety and 
Occupational Health (ESOH) personnel.  Dr. Leigh’s and Dr. Grant’s efforts form the 
backbone of our research efforts.  Follow-on efforts by other researchers provide 
refinement and deeper discussion of the challenges of modeling occupational illness 
costs.  
Historical Perspective 
 Occupational illness prevention has long been recognized as a critical component 
of creating a safe and healthy workplace.  In the late 1960s, President Richard Nixon 
pointed out the need for increased emphasis on workplace health (Burk & Moeller, 1975: 
2).  In a message to Congress, President Nixon compared the adequacy of federal safety 
and health programs to private businesses.  Apparently, federal program administrators 
were not keeping up with the advances in technology and manufacturing.  As a result of 
proposed standards, Congress created the Occupational Safety and Health Act of 1970 
(Ibid: 3).  However, the act specifically excluded federal agencies by defining an 
employer as “…a person engaged in a business affecting commerce…” (Ibid).  Upon 
further refinement of OSHA directives, Air Force leaders created Air Force Occupational 
Safety and Health (AFOSH) equivalent regulations.  In fact, the verbiage of the Air Force 
regulations called for safety and health standards equal to or better than OSHA standards.  
AFOSH programs have since evolved under several organizations, such as Air Force 
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ESOH, Air Force Institute of Occupational Health (AFIOH), and finally the U.S. Air 
Force School of Aerospace Medicine, located at Brooks City-Base, Texas.  
The Air Force definition of occupational illness is “any abnormal condition or 
disorder, other than an occupational injury, caused by exposure to environmental factors 
related to employment” (Grayson, 1990: 2).  The Occupational Safety & Health 
Administration (OSHA) defines occupational illness as a physiological harm or loss of 
capacity produced by systematic infection; continued or repeated stress or strain; 
exposure to toxins, poisons, fumes, etc.; or other continued and repeated exposures to 
conditions of the work environment over a period of time. For practical purposes, an 
occupational illness or disease is any reported condition not meeting the definition of 
traumatic injury (www.osha.gov).  To properly differentiate between injuries and 
illnesses, consider that injuries are a result of an instantaneous event whereas illnesses are 
usually a result from repeated exposure over time. 
Cost/Benefit Analysis Methods 
 In 2001, Dr. Katharyn Grant created a technical guide to assist ESOH workers 
with creating economic or cost-benefit analyses.  Engineers could then use the analyses to 
enhance recommendations for ESOH solutions at Air Force installations (Grant, 2002: 1).  
Dr. Grant noted that cost has always been a significant factor when evaluating workplace 
changes.  She highlighted the importance for ESOH professionals to fully understand 
costs associated with their recommendations.  Decision makers usually understand 
benefits expressed in financial terms.  Dr. Grant’s report provides the tools necessary to 
express costs and benefits in a manner in which decision makers should readily 
understand (Ibid). 
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 Cost/benefit analyses generally follow a common path of evaluation steps (Ibid).  
The basic plan of action for most economic analyses is: 
• Define project goal or desired outcome 
• Identify potential alternatives 
• State assumptions 
• Determine costs 
• Detemine benefits 
• Compare costs/benefits for alternatives 
• Perform sensitivity analysis 
• Select alternative with most advantageous mix of costs/benefits 
Properly comparing costs and benefits is perhaps the most challenging technical aspect of 
performing an economic analysis.  Three methods were compared: net present value, 
payback method, and return on investment.  Those methods will be discussed and 
compared in the following paragraphs. 
 Net present value (NPV) provides one value of all costs and benefits across the 
life of a project.  Future costs and benefits are discounted back at an appropriate rate to 
provide an accurate comparison of expenditures or benefits occurring at different times.  
See Chapter 3, Methodology, for further explanation of discounting.  The NPV formula 
is:  
    NPV = FV (1 / 1 + r)t – IC                              (1) 
where NPV is net present value, FV is future value of benefits, r is the discount rate, t is 
the number of time periods the cost or benefit occurs, and IC is the initial capital expense 
12 
 
of the project (Ibid: 10).  ESOH professionals may compare the NPV for a number of 
options.   
Any NPV above zero means the benefits outweigh the costs.  For example, 
consider making a choice between Option A and Option B.  Option A requires an initial 
capital expense of $100 but returns a $200 benefit in 3 years.  Option B also costs $100 
upfront but returns a $50 benefit in 3 years.  Using Equation 1 with a 7% value for r, we 
see that Option A provides a NPV of $63.26.  Option B provides a NPV of -$59.19.  
Option A is better than Option B because Option A has a positive value.  Option B costs 
more money than it provides over the life of the project.  From a strictly financial 
viewpoint, the alternative with the highest NPV will normally be the best choice.   
 Instead of comparing the NPV of alternatives, decision makers may want to know 
how quickly their “investment” will pay for itself through reduced costs.  Such an 
analysis is known as the payback method.  The payback method formula is: 
     PB = C / S            (2) 
where PB is the payback period (months, years, et cetera), C is the initial cost, and S is 
the recurring benefit or savings.  If the payback period is negative, the alternative costs 
more than it saves (Ibid: 12).  This method of economic analysis is flawed for several 
reasons.  First, the method does not consider any cost or benefits beyond the payback.  
Second, while some methods of payback incorporate discounting or time value of money, 
Dr. Grant’s simplified version shown in Equation 2 does not.  Finally, the benefits must 
be fairly consistent for this equation to work properly.  For example, if the initial cost was 
$100 and the recurring savings per period was $50, we calculate a payback period of 2 
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periods.  However, based on these inherent flaws of this methodology, the payback 
method will not be considered as a viable option. 
 Finally, leaders may want to know the return on their investment.  Return on 
investment (ROI) “represents the percentage of the costs associated with implementing a 
project that are recovered as savings over a set period of time” (Ibid).  The formula for 
ROI is: 
          ROI = (S / C) * 100%           (3) 
where ROI is return on investment, S is the annual benefit or savings, and C is the initial 
cost.  The ROI method is useful in showing what percentage of the initial cost is 
recovered for each time period.  This method may be useful as a secondary consideration.  
However, ROI does not convey the magnitude of cost or benefits.  For example, a project 
with annual savings of $5,000 and initial cost $100,000 will have the same 5% ROI as a 
project with annual savings of $100 and initial cost of $2,000.  Commanders are often 
constrained by a one-year budget cycle for specific appropriations.  The dollar value of 
costs and benefits is often a huge limiting factor, and ROI does not convey this 
information directly.  
Occupational Illness Modeling  
Perhaps the most relevant literature regarding parametric estimation of indirect 
costs appears in Occupational Injury and Illness in the United States: Estimates of Costs, 
Morbidity, and Mortality.  Dr. J. Paul Leigh, et al, provided an early attempt at 
quantification of direct and indirect injury and illness costs in the United States.  Indirect 
illnesses include lost earnings, lost home production, and lost fringe benefits (Leigh, 
Markowitz, Fahs, Shin, & Landrigan, 1997: 1557).  The authors tied the occurrence of 
14 
 
certain illnesses in the United States to the probability of the illness occurring due to 
occupational conditions.   
The authors provided confidence intervals of illness occurrence along with point 
estimates.  It is important to distinguish between the two now.  Point estimates are 
convenient, allowing the end user to have a specific number for further estimates and 
calculations.  However, the confidence interval approach provides a more realistic, 
accurate range of possible values.  This is especially true when using the ranges to 
provide potential future costs.  For example, it cannot be said with much fidelity that 8% 
of all cardiovascular disease cases in the next five years are work-related.  However, 
based on documented research, researchers can estimate that 6% to 10% of 
cardiovascular disease cases may be work-related (Leigh J. P., Markowitz, Fahs, & 
Landrigan, 2000: 60).  Uncertainty may hamper the acceptance of cost models.  It is 
critical for the cost analyst to communicate the meaning and importance of confidence 
intervals when delivering cost estimates to the decision makers.  Even so, Dr. Leigh also 
used point estimates calculations in order to streamline estimation processes.  Dr. Leigh 
assumes a normal distribution for the attributable factors, and we will assume likewise.   
 Some illnesses are mostly attributable to a particular job, such as mesothelioma 
and pneumoconiosis (Ibid: 66).  Other illnesses occur “naturally” and through exposure 
to catalysts in and out of the workplace, such as many forms of cancer (Leigh J. P., 
Markowitz, Fahs, Shin, & Landrigan, 1997: 1559).  The authors applied an attributable 
risk proportion model for illnesses not 100% attributable to work.  The model was 
created using results from numerous existing medical studies relating specific diseases to 
what proportion resulted from work-related exposures.  Other studies acknowledge the 
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increased risk of cancer in some occupations without clearly identifying the specific 
causes.  For example, farmers may have higher rates of lymphoma and fire fighters may 
have higher rates of brain cancer (Ibid).  Also, smoking warrants special consideration.  
Smoking is a personal choice and should not be included as a workplace toxin exposure.  
Conversely, the effects of second-hand smoke should be included for certain occupations 
where workers are constantly exposed, such as bars and some restaurants.   
The cost model developed by Dr. Leigh, et al, uses present value as shown below: 
PVDeath = Σ Py,s,n * (Ms,n + Hs,n + Fs,n) * LFPRs,n * (1+g)n-y/(1+r)n-y                              (4) 
*Note: Summation is from y = n to 75, representing a range of possible working years. 
Above, PVDeath is the present discounted value of loss from illness; Py,s,n is the probability 
a person of age n, sex s will survive to age y; Ms,n is the mean annual earnings of a person 
of sex s and age n; Hs,n is the value of household production of a person of sex s and age 
n; Fs,n is the fringe benefits, again based on sex s and age n; LFPR is the labor force 
participation rate (0.0 to 1.0); g is the increase in labor productivity, assumed by the 
researchers to be 1%; and r is the real discount rate, assumed to be 4% (Ibid: 1561).  
Mean annual earnings includes direct salary.  Household production includes the value of 
household services such as lawn care, general repair, cooking, cleaning, et cetera.  
Examples of fringe benefits include loss of vacation time and loss of employer/employee 
contribution to retirement accounts.  The household production and fringe benefits, as 
well as the mean salary based on demographic data, may oversimplify the true value of 
loss from illness or injuries.  However, to date, it represents the best attempt at capturing 
these elusive costs and modeling the estimates for further research.    
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Based on the number of reported illnesses and the estimated portion of those 
illnesses occuring due to occupational exposure, the authors determined there were 
approximately 817,000 to 907,000 new occupational illnesses in the United States in 
1992.  As shown in Table 1, the task of estimating the number of occupational illnesses is 
very challenging.  The numbers of occupational illnesses are not readily tracked by a 
central database.  Different databases track different sectors of the workforce, and the 
possibility to miss counting illnesses or double-counting illnesses is ever present.  Table 1 
provides an excellent snapshot of how daunting a task it is to calculate the number of 
illnesses occuring in this country based on occupational exposure. 
Table 1 also provides good rationale to implement the recommendations included 
in Chapter 5.  Concise, purposeful, accurate databases would negate the ambiguous 
ranges of illness and injury occurring in the United States.  Without a firm number of 
cases to start with, one cannot hope to accurately estimate total costs.  We are 
immediately faced with much uncertainty, which will only increase as attributable factor 
ranges are added to the estimation. 
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Table 1.  Number of Illnesses, US (1992)   
(Reproduced with permission from J.P. Leigh et al, 1997) 
 
The authors used a median value of 858,165 occupational illnesses for further 
calculations.  Using Equation 4, the direct cost of occupational illness for this time period 
was 16.07 billion dollars and the indirect cost was 9.47 billion dollars, as shown in Table 
2.  To summarize, the authors calculated each dollar of direct costs results in 59 cents of 
indirect costs (Ibid: 1562).  If only $1 out of $1.59 is being captured, this equates to 
approximately 37% of the total cost of occupational illness not being captured.  This is in 
stark contrast to previous estimates of $6 to $53 of indirect costs for each $1 of direct 
costs.  The extreme difference may be due to other indirect cost factors not captured in 
the Leigh et al model.  Or, it may mean earlier estimates were greatly overstated. 
Illness/Source of Data
Estimated 
Attributable 
Number of New 
Cases in US
Percentage 
Attributable 
to 
Occupation
Estimated Number of Occupational 
Illnesses
Cancer 1,113,100 6% - 10% 66,790 - 111,130
Coronary heart 
disease
730,000 5% - 10% 36,500 - 73,000
Cerebrovascular 
disease
101,00 - 144,000 5% - 10% 5,050 - 14,400
Chronic obstructive 
pulmonary disease
1,500,000 10% 150,000
Subtotal 258,340 - 348,710
Bureau of Labor 
Statistics Annual 
Survey
457,400
National Institute of 
Occupational Safety 
and Health
14,250
Public Sector 
Employees
92,010
Total* 817,015 - 907,385
* Approximately 5,000 cases removed to avoid estimation overlap
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Table 2.  Number and Costs of Illnesses, US (1992)   
(Reproduced with permission from J.P. Leigh et al, 1997) 
     
 Number Direct Cost Indirect Cost Total 
     
Deaths 60,293 $10.70B $9.00B $19.70B 
     
Morbidity 858,165 $5.37B $0.47B $5.84B 
     
Totals  $16.07B $9.47B $25.54B 
 
 In Dr. Leigh’s sensitivity analysis, he notes that he did not adjust discount rates or 
growth rates in the present value model. His team found various discount rates did not 
greatly alter the findings.  Significant cost variation depended on the numbers and types 
of illnesses instead of discount/growth rate changes. 
 The indirect costs may be underestimated due to the exclusion of pain and 
suffering.  Additionally, the medical cost data excluded California and New York due to 
the disproportionately high cost of healthcare in these two states.  Finally, the estimates 
ignored the value of home care provided by the family, effects of disabled or absent 
parents, and wage losses attributed to disabled persons employed in relatively less 
lucrative jobs (Ibid: 1565). 
 The article provides an excellent framework for this research effort.  The authors 
provide ample explanation as to why cost estimates for indirect costs had such a large 
range.  Unless illnesses are attributable to workplace exposure, the cost of occupational 
illness cannot be accurately estimated.  To further complicate matters, most illnesses do 
not surface until many years after exposure, making it more difficult to tie back to a 
particular workplace.   
19 
 
Economic Value of Occupational Health Services 
  Miller, Rossiter, and Nuttall attempted to determine an economic value of 
occupational health services in a workplace (Miller, Rossiter, & Nuttall, 2002: 477).  
While the study was based in the United Kingdom, the external validity of the study 
allows analysts to make several direct comparisons.  To start, the cost of sick workers is 
easy to determine.  The authors show the total cost of sickness absence led to 12 billion 
British Pounds, simply based on the average lost working days per year and the average 
cost per worker per day.  While such generalizations may not be very accurate in the 
aggregate, one cannot overlook the impact occupational health services may have in 
reducing these costs (Ibid: 478). 
 There is a major problem with measuring the impact of occupational health 
investments.  The impact is the absence of an occupational illness or injury.  Counting the 
number of times something does not happen is a challenge.  Developing a causal 
relationship between an illness not occurring and the expenditures made on occupational 
health may be impossible.  Measuring a reduction in illnesses may be more appropriate.  
But, other causes may exist.  For instance, a new commander can redirect the corporate 
culture, focusing more on process improvement, safety, and proficiency.  Any one of 
these factors, in addition to increased morale, could lead to a reduction in illness.  
Controlling for every alternate explanation is nearly impossible, especially when 
organizational leaders want assurance they are spending money on effective programs.    
 The first model compared the direct cost of administering an occupational health 
service within an organization to the expected benefits.  If the benefits exceeded the 
costs, the program was justifiable.  Such benefits included increased health and morale, 
20 
 
increased performance and productivity, reduced medical/legal costs, enhanced 
workplace safety, and reduced sickness absence (Ibid: 479).  A few drawbacks 
immediately come to mind.  It seems only three of the five broad categories are 
quantifiable.  While absences, productivity or medical costs can be measured, health, 
morale, and workplace safety are not as easy to quantify.  Even so, this simple break-even 
analysis has merit and may be an appropriate area of future research. 
 Next, the authors attempted to give a valuation to occupational health services by 
surveying 38 key decision makers.  The decision makers were asked to give a 
hypothetical monetary estimation, comparable to an insurance premium making an 
occupational health service desirable.  The authors calculated the difference between the 
hypothetical estimate and the actual premium to determine the “net value added” (Ibid: 
480).  This method evaluates a manager’s perception of the value of a service, 
introducing a fair amount of subjectivity into the process. 
 Finally, the authors employ an empirical approach with primary data collection.  
Three categories of outcomes of occupational health services were developed.  The first 
category is unobservable outcomes, such as reducing risk and increasing safety 
awareness.  The second category is clearly observable outcomes, such as sick days, health 
costs, and frequency of illnesses.  The third category is outcomes which must be 
“estimated by proxy, using other observable data” (Ibid: 481).  The quality of life of 
employees is a major element in the authors’ empirical approach to modeling costs.  
However, the authors do not move beyond the concept of empirical modeling.  They limit 
discussion to developing some type of cost per quality-adjusted work day factor without 
showing an actual model or empirical results. 
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 Managers may not fully understand the costs or benefits of occupational health 
services.  From a purely business standpoint, key decision makers may only need to know 
the benefits outweigh the costs.  If this is the case, analysts would only need to quantify 
occupational health benefits to the break-even point.  One must consider the costs of 
long-term solutions, as well.  There is much uncertainty involved when quantifying 
benefits to an employee after he or she has been retired for 10 years.  This approach may 
lead to minimizing costs or overstating benefits to reach favorable conclusions.  Clearly, 
a more empirical approach is desired. 
Social/Economic Impacts of Workplace Illnesses 
 Occupational illnesses have many impacts.  Workers, employers, families, and 
society as a whole are all impacted.  There are monetary costs and social costs.  It is 
troubling that only a fraction of the total “bill” is understood.  Some estimates suggest for 
every week a worker is off the job due to an occupational illness or injury, he or she loses 
an average of ten thousand dollars in earnings (Boden, Biddle, & Spieler, 2001: 399).  
Employees lose direct wages when they become sick or injured.  Additionally, they may 
lose their place in seniority or promotions and may have to accept other jobs with lower 
pay to accommodate any limitations imposed by the illness or injury.  This figure, of 
course, depends on the type, severity, and duration of illness, as well as the employee’s 
socio-economic status before, during, and after the illness.  The authors point to research 
showing ill workers are unable to fulfill social, work, or family roles.  The resulting 
“diminished earnings, long-term physical limitations, depression, fear, and anger” further 
increase their psychological and economic suffering (Ibid). 
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 In the past, the only costs most employers considered stemmed from worker’s 
compensation.  However, worker’s compensation is just one of many other factors.  As 
noted earlier, indirect costs include such things as training and hiring replacement 
workers, lost productivity, downtime, redundancy as a risk management strategy, and 
decreased morale/public relations.  To make matters even more complicated, the 
aforementioned costs will vary greatly depending on the occupation, 
frequency/severity/duration of illness, and a host of other demographics.  The expansive 
list of variables presents a considerable challenge to developing an all-encompassing 
indirect occupational illness cost model.  The poor quality and quantity of available data 
does not help the issue (Ibid: 401). 
Estimating Indirect Costs of Illness: Assessing Forgone Earnings 
 One of the biggest indirect costs of occupational illness is the loss of earnings 
experienced by an employee.  Calculating these forgone earnings would capture a 
significant portion of the indirect cost “iceberg.”  However, there are serious issues with 
relying solely on forgone earnings calculations.  As Dr. Glied points out, “while the 
forgone earnings approach is certainly less complicated than measuring willingness to 
pay for increased risk, it will not provide appropriate or consistent estimates unless it is 
used with great care” (Glied, 1996: 1728).   
 The forgone earnings approach methodology allows the analyst to approximate 
the wages an employee would have likely earned had he or she not become ill or injured.  
The average earnings of a cross-sectional pool of people sharing similar demographics 
are discounted back to an established base year.  The forgone earnings equation is as 
follows: 
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Forgone earnings = ∑ En+i, m                                                      (5)  
where E is the estimated earnings for a person age n in year m.  The summation is from 1 
to i, based on the necessary span of time.  The author uses a generic time period of 15 
years in the study.  However, a 20-year old individual will likely require longer analysis 
while a 60-year old individual may require less.  In the study, the author shows a 20-year 
old Caucasian male would likely earn $161,157 in the 15 years spanning from 1973 to 
1988.  The dollar figure is set to a base year of 1980, discounted at 4% per anum.  The 
actual earnings for this group and time period were $128,723.  This particular example 
shows a resulting error of 20.1%, one of the worst error rates when comparing the 
author’s estimations to actual earnings for particular groups and times (Ibid: 1725-1726). 
There are some marked problems associated relying solely on the forgone 
earnings approach.  First, this approach is only useful if calculating earnings forgone due 
to death.  Otherwise, it would be difficult to determine the length of time an individual 
will remain out of work due to the injury or illness.  Even so, using the average life 
expectancy based on the age of the individual at the time of death introduces its own 
source of error.  Also, there is an enormous amount of variation in the estimates, as 
shown in the above paragraph.  Business cycles, advances in technology, labor market 
conditions, and population changes all impact earnings estimates.  Finally, the younger 
the employee is at the time of death/injury/illness, the more divergence present in the real 
earnings growth.  Sensitivity analyses may help control for some of these sources of 
error.  The extreme variance of forgone earnings estimates and substantial impact of 
external factors (business cycles, labor markets, et cetera) will not provide decision 
makers the clean, accurate, and convenient indirect cost estimate they may desire.   
24 
 
Magnitude of Mortality 
 Dr. J.P. Leigh et al developed the first relatively transparent occupational illness 
cost model by estimating the portion of illnesses attributable to occupational exposure.  
Dr. Kyle Steenland et al used similar attributable factors to specifically determine the 
magnitude of deaths from a specific set of diseases.  By analyzing causes of death in the 
U.S. in 1997, Steenland et al gathered International Statistical Classification of Diseases 
and Related Health Problems codes, 9th Edition (ICD-9).  The ICD-9 codes are used by 
medical professionals to describe illnesses and injuries, making computer data entry and 
analysis more efficient.  Each ICD-9 code is directly related to a particular illness or 
injury.  The authors calculated attributable factors for a specific set of illnesses and 
multiplied the factors by the total number of the illnesses reported in 1997.  The 
following is a list of illnesses reviewed in the document: pneumoconiosis, occupational 
asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, and specific 
cancers.  The attributable factor equation is as follows: 
Attributable Factor  =       P (E) (RR – 1)   
 While the attributable factors were used for most diseases, some diseases 
warranted special attention.  For instance, it can be argued pneumoconiosis is 100% 
attributable to occupational exposure (Ibid: 464).  The attributable factor for COPD was 
taken from “community-based studies of the general population rather than from 
                                  (6) 
                               1 + P (E) (RR – 1) 
 
Where P (E) is the proportion of the general population exposed to a particular agent, and 
RR is the relative risk of death or disease for someone exposed as compared to someone 
not exposed (Steenland, Burnett, Lalich, Ward, & Hurrell, 2003: 463). 
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workplace- and industry-specific studies” (Ibid: 465).  Other case-specific adaptations 
were made in the study, such as eliminating causes of death with less than 50 deaths in 
the year.  Also, occupational noise, shift work, and second-hand tobacco smoke were not 
considered as a cause of death themselves, but as compounding factors to other causes of 
death such as coronary heart disease.  Table 3 shows Steenland’s results for job-related 
deaths caused by illness in 1997.  This table once again points out the complexity of 
quantifying victims of occupational illness.  The wide range of deaths reported by 
Steenland in Table 3 and the range reported by Leigh in Table 1 lend some credibility to 
the wide variance in indirect costs initially reported by Basu and Wright in Figure 1. 
Table 3. Estimated Number of Job-Related Deaths Due to 
Illness, US (1997)   
(Reproduced with permission from Dr. Kyle Steenland et al, 2003) 
 
 
 The authors acknowledge the results were “broadly consistent” with other 
estimation efforts such as Dr. Leigh’s (Ibid: 474).  However, several sources of potential 
underestimation and overestimation were noted.  The results could be underestimated due 
to the limited set of diseases captured in the study.  Many diseases are believed to be 
caused by occupational factors but were excluded unless scientific research established a 
Cause Number of Occupational Deaths
Selected Respiratory Diseases
Selected Cancers
Coronary Heart Disease
Selected Renal Diseases
Other Occupational Diseases
Total
328 - 580
50 - 350
25,910 - 72,121
6,805 - 26,686
12,086 - 26,244
6,037 - 18,253
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direct relationship.  Also, diseases were excluded if less than 50 deaths were reported.  
Overestimation could take place when developing confounding attributable factors, such 
as how or if smoking increases the risk for coronary heart disease.  Also, estimating a 
composite attributable factor for several diseases or risk factors could lead to 
overestimation.  The mortality estimation results place occupational disease-related 
deaths as the 8th leading cause of death in 1997, after diabetes but before suicide.  To add 
some perspective, deaths from occupational-related diseases are estimated to be greater 
than yearly motor vehicle deaths (Ibid: 477).   
 As the aforementioned research efforts clearly demonstrate, modeling 
occupational illness costs is difficult.  There is uncertainty in the exact number of 
illnesses as well as the percent caused by occupational exposure.  After considering the 
DoD’s approach to estimating illness costs, we will build upon the tools and techniques 
developed in previous research efforts by developing a methodology to model 
occupational illness costs for Air Force personnel. 
Accident Investigation, Reporting, and Record Keeping 
 The Department of Defense, in compliance with OSHA guidelines, has 
established its own accident/illness investigation, reporting and record keeping.  DoD 
Instruction 6055.07, updated in April 2008, outlines the processes for the aforementioned 
activities.  These processes are specifically developed to comply with federal job safety 
mandates, such as Executive Order 12196 and 29 Code of Federal Regulations (CFR) 
1960 (Defense, 2008: 2).   
 DoD policy authorizes the implementation of workplace programs for two 
purposes: 
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1.  “Investigate, report, and keep related records on accidental death, injury, 
occupational illness, and property damage for DoD accidents covered by this 
Instruction and/or specific statutory authority (Ibid).” 
2.  “Prescribe and enforce regulations directly related to investigation, reporting, 
and keeping records on accidental death, injury, occupational illness, and property 
damage (Ibid.)” 
Such programs may help leaders utilize historical data as appropriate when developing or 
acquiring new acquisition systems.  The data may also be used to estimate future costs 
based on past experience.   
To aid in estimating future costs, DoD personnel developed cost estimation 
factors in 1988.  The factors estimate costs when personnel succumb to illness or injury 
on the job.  We attempted to ascertain the methodology behind the DoD cost factors.  
Unfortunately, the methodology is not available, either due to lack of continuity or 
unfamiliarity with illness estimating techniques. As stated in the document, “They [cost 
factors] were developed in 1988 and have not been updated so that analysts can make 
generalized comparisons against historical data (Defense, 2008: 35).”   
Fortunately, we are able to properly analyze historical Air Force medical cost data 
for the past 10 years in order to update or validate the outdated cost factors for the DoD.  
To summarize Table E7.T1, Cost Standards, enlisted and commissioned personnel cost 
$120 per day for illness resulting in no lost time.  We assume no lost time simply means 
an employee falls ill at work, seeks care at a treatment facility, then returns to work on 
the same day or at latest the following day.  For illnesses resulting in hospitalization, 
enlisted and commissioned personnel cost $466 per day.   We assume days of 
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hospitalization equate to bed days as reported by medical cost databases.  Again, these 
figures are based in 1988 dollars. 
The DoD Instruction adequately outlines responsibilities, processes, and other 
administrative issues.  However, there is no mention or reference as to how the cost 
factors were developed.  We seek to validate these factors or recommend updated factors 
for more accurate illness cost estimating for the DoD. 
Now that we have examined existing relevant research, we can develop a 
methodology that will allow us to answer our research questions.  First, we will develop a 
suitable cost/benefit analysis tool.  Then, we will develop a methodology to analyze the 
DoD cost factors. 
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III. Methodology 
Cost Comparison Analysis 
Net Present Value. 
To begin discussion of cost/benefit analysis methods, some basic assumptions 
must be established.  Many economic analysis methods incorporate a discount rate in the 
calculations.  Discount rates determine the required return rate of investing capital.  The 
basic premise of including a discount rate is to account for the time value of money.  
Simply put, it is cheaper to spend money later versus now.  It is better to earn money now 
versus later.  We will use discount rates to quantify the potential costs and benefits of 
investing government appropriations.  
Government appropriations are much different than corporate funding because 
they are not impacted as much in terms of traditional interest rates for borrowing or 
lending.  When a commander needs capital to build a new road, she either uses available 
funds or asks higher headquarters for more budget authority.  To simplify discussion, 
there are no bonds to issue, stocks to sell, or loans to take.  Operations and Maintenance 
(O&M) funds are generally available for only one year.  However, interest rates can enter 
the picture when the time frame exceeds one year.   
According to Air Force Manual 65-506, Economic Analysis, analysts should use 
an interest rate equal to a 3, 5, 7, 10 or 30 year Treasury bill/bond when evaluating the 
net present value of a potential project.   It is important to distinguish between interest 
and discount rates.  Interest rates are the cost of borrowing money and discount rates are 
the expected return on the capital investment.  The two concepts are similar and are even 
used interchangeably in some texts.  The timeline of the project will dictate the applicable 
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Treasury rate to use (SAF/FMC, 2004: 10).  The Treasury rates are essentially the 
government’s cost of borrowing money.  As such, the rates serve as a proxy for 
discounting government appropriations to determine a net present value.   
In contrast, the OMB states a 7% rate shall be used (whitehouse.gov).  We feel 
this set 7% rate is simple, effective, and robust enough for the types of cost/benefit 
analyses to be conducted by bioenvironmental engineers.  The OMB rate removes one 
more variable from the equation, simplifying the process even more.  Further, Dr. Leigh’s 
previously mentioned research showed the interest rate or discount rate was not a 
significant factor in the sensitivity analysis.   
 Net present value is a method of determining a value of an alternative at a given 
point in time.  All costs and benefits are expressed in terms of a common time.  Future 
costs and benefits are discounted back at an appropriate interest rate.  As noted earlier, 
the Air Force Manual 65-506 contains methodology for discounting by using Treasury 
Bill rates.  To demonstrate net present value, consider the following example.  
 
  Time 0            $200 
                         
   $100            Time 1 
The above timeline represents an initial cost of $100 at Time 0, noted by the downward 
pointing arrow, and a future expected benefit of $200 at Time 1, noted by the upward 
pointing arrow.  Assume a nominal interest rate of 7%, as recommended by the OMB.  
Whether or not spending $100 now to receive $200 in the future depends on two factors.  
The first factor is time, specifically the length of time between an expenditure and the 
31 
 
receipt of any future benefit.  The second factor is the interest rate.  Recall from Equation 
1 the formula for net present value: NPV = FV (1 / 1 + r)t - IC.  The present value of the 
$200, discounted back one period at 7% equals $186.92.  The net present value is simply 
the present value of future benefits minus the present value of current and future costs.  In 
this example, simply subtract $100 from $186.92 to get a net present value of $86.92.  
This value represents the value of benefits above and beyond any costs incurred.  As long 
as the net present value is greater than zero, it makes financial sense to make the 
investment.   
 Equivalent Annual Cost. 
 Net present value is a powerful tool for determining when to make an investment.  
However, it may not be the best analysis method when evaluating government, or public-
sector, projects.  Public-sector economic problems are often more difficult than private-
sector economic problems for several reasons including (Eschenbach, 2003: 363): 
• Benefits are difficult to determine/quantify in terms of money 
• Long time horizons increase risk 
• Policy/bureaucracy challenges 
• Interest rate selection is difficult 
To further complicate matters, the short annual cycle of O&M funding hampers decision 
makers from fully considering future costs and benefits of a project.  Most decision 
makers tend to focus on the annual impact to the overall budget.  The Equivalent Annual 
Cost (EAC) is the solution to this problem. 
 The EAC is a uniform dollar amount at the end of each period, equal to the 
overall costs for a project (Ibid: 139).  The EAC will allow comparison of equivalent 
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annual costs between two alternatives, giving commanders an “apples to apples” 
comparison of the long-term impact on a budget.  Using some simple equations, the EAC 
can be calculated based on a known present value or cost.  The formula for computing an 
EAC based on a present value is: 
    EAC = (PV*((i*(1 + i)N)/((1 + i)N – 1))) + RC                            (7) 
where PV is the present value of the initial cost, i is the discount rate, N is the number of 
periods, and RC is the recurring cost. 
While the formula may initially appear daunting, there are several ways to 
automate the process such as using a financial calculator, spreadsheet tool, or using end-
of-period compound interest factors available in many economic text books.  We will use 
a spreadsheet tool to simplify comparisons.  The formulas above can be programmed into 
a write-protected worksheet, allowing engineers to make quick calculations and evaluate 
alternatives.  The following is a screenshot of a possible spreadsheet-based analysis tool: 
Figure 2.  Excel®-Based Equivalent Annual Cost Tool  
 
 
**Only change cells highlighted in yellow Life Span (years) 10
**Lowest EAC is best option financially Interest Rate 7.0%
Initial Cost -$                Initial Cost 21,000.00$  Initial Cost 10,000.00$  
Recurring Cost 6,500.00$      Recurring Cost -$              Recurring Cost 3,125.00$    
EAC 6,500.00$      EAC 2,989.93$    EAC 4,548.78$    
Option 1 Option 2 Option 3
$-
$1,000.00 
$2,000.00 
$3,000.00 
$4,000.00 
$5,000.00 
$6,000.00 
$7,000.00 
$6,500.00 
$2,989.93 
$4,548.78 
Equivalent Annual Cost
Option 1
Option 2
Option 3
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In Figure 2, three options are compared with differing initial and recurring costs, but 
similar life spans and discount rates.  Option 1 has no initial cost, but a high recurring 
cost each year.  The EAC for Option 1 is equal to the recurring cost.  Option 2 has the 
highest initial cost, but no recurring cost.  The EAC for Option 2 is the initial cost spread 
across the life span of the project (10 years), discounted by the interest rate of 7%.  
Finally, Option 3 has a lower initial cost compared with Option 2 and a lower recurring 
cost compared with Option 1.  The EAC for Option 3 is the initial cost spread across the 
life span of the project (10 years) plus the recurring cost per year.  As shown in the bar 
graph, Option 2 is the cheapest in terms of equivalent annual cost, followed by Option 3 
and then Option 1.  This is a good example of how decision makers may be misled by 
high initial costs in favor of an affordable recurring cost.  Even though Option 2 would 
require a substantial investment up front, it is the cheapest option in terms of equivalent 
annual cost. 
 Breakeven Analysis. 
In addition to EAC, commanders may also want to know at what point options 
become more expensive than one another.  A breakeven analysis will show the best 
option for a given range of time.  Again, spreadsheet applications can easily be 
programmed to display a line graph.  The lowest line for any given time is the cheapest 
option.  The options have equal EACs at the intersection points.  This method also allows 
some sensitivity analysis by allowing the decision maker to determine at which time 
period the options are equal.  If there is uncertainty in the lifespan of the project or 
equipment to be purchased, the breakeven analysis can help show at what range the 
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project or expenditure is still viable.  Figure 3 shows an example of a spreadsheet tool for 
breakeven analyses: 
Figure 3.  Excel®-Based Breakeven Analysis Tool 
 
 
The same initial and recurring cost information from the EAC example were used.  The 
resulting analysis shows Option 1 is the cheapest for Year 0 to Year 3.4.  Option 3 is 
cheapest from Year 3.4 to Year 3.7.  Option 2 is the cheapest past Year 3.7.  Decision 
makers must take into account the likely life span for a given project, as this could greatly 
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influence the outcome.  This graph allows the user to determine the sensitivity of time 
effects in the analysis. 
 The breakeven lines shown in Figure 3 were developed using Equation 7 to 
calculate the EAC for each option for each period of comparison.  For example, Option 2 
EAC for a life span of one year is $21,400.  When we increase the life span to two years, 
the EAC drops to $11,061.84.  For three years, it is $7,621.03.  As the projects are spread 
out over longer periods of time, the resulting EACs are generally smaller.  As shown by 
Option 1, the EAC will not change if there is no initial capital cost.  The EAC is equal to 
the recurring costs each year.  When we plot the EACs for all options across a range of 
project life spans, we can see where one project becomes more expensive than the others.  
Simple spreadsheet commands will even return the exact point where the EACs intersect, 
as well as show the intersects graphically.  
Validating DoD Cost Factors 
The second area of methodology focuses on validating occupational illness cost 
factors created by the DoD in 1988.  Most previously cited methodology estimates the 
direct and indirect cost of occupational illness by summing up what is spent to treat the 
illness and what is lost due to a person having the illness. Direct costs include medical 
expenses and disability payments.  Indirect costs include forgone earnings, fringe 
benefits, home production, lost productivity, turnover, and retraining.  The basic total 
illness cost equation is 
  Total Cost = Direct Cost + Indirect Cost                                    (8) 
Equation 8 is the foundation of understanding occupational illness costs.  We will 
develop refined methodology in later sections that modify this basic equation as needed.  
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As we develop specific methodology to quantify direct and indirect costs for Air Force 
personnel, we will continually adjust this basic form of the equation to arrive at the final 
model. 
            Direct Medical Costs. 
 While both medical and disability costs are considered to be direct costs, this 
research project will focus solely on medical costs.  Disability costs are normally paid 
through the Department of Veterans Affairs, although there is some disability paid from 
the DoD in the early stages of compensation for a service member.  We will not consider 
costs outside of the Department of Defense appropriations, particularly since the author is 
attempting to show the impact to an organization funded through DoD appropriations.  
Military medical expenses, consisting of military care and purchased care, were provided 
to the author through a contracted data retrieval service for the Air Force Surgeon 
General’s (AF/SG) office.  Medical cost data is available for 1999 through 2008 and is 
broken down into fiscal year, illness, rank, age group, gender, then year cost, and bed day 
or frequency, depending if the cost was due to hospitalization or an outpatient visit.  It is 
important to note the medical cost data was provided in then year dollars.  Then year 
dollars show the cost of care in the year care was provided.  Just as we cannot compare 
the price of a loaf of bread from today with 30 years ago, we cannot compare medical 
expenses occurring in different years.  We need to adjust all costs to a base year, or 
common year, so comparisons can be made.  The following section addresses 
normalizing direct medical costs to overcome this problem. 
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Normalizing Direct Medical Costs. 
Generally, the price of goods and services increase over time due to inflation.  
The Bureau of Labor Statistics (BLS) provides inflation factors for goods and services, 
allowing us to see the effects of inflation over time (bls.gov).  One must normalize costs 
occurring in different years before any analysis can be done.  For our purposes, 
normalization simply means adjusting costs from different time periods to a common 
time period to account for normal increases in prices over time.  The Consumer Price 
Index will allow us to compare prices from different years and distinguish price increases 
due to inflation and price increases due to simply higher cost.  Unfortunately, BLS does 
not provide a convenient tool for us to normalize medical costs, so we will create one. 
SAF/FM has an online tool on the Air Force Portal to convert then-year dollars to 
base-year dollars.  Unfortunately, the Air Force cost conversion tool does not help 
because of the unique nature of Defense Health Program (DHP) appropriations.  DHP 
appropriations are a mix of Operations and Maintenance, Procurement, Personnel, and 
Research/Development/Testing dollars.  There is no tool available to convert mixed 
appropriations. 
 To overcome the mixed nature of DHP appropriations, we used the Consumer 
Price Index – Medical (CPI-M) database (bls.gov).  CPI-M measures the inflation of 
medical costs over time.  Table 4 shows the CPI-M inflation data as well as the normal 
CPI inflation data for 1999 through 2008 (Ibid).  We use these values to build an index 
allowing us to convert then-year medical costs to a base year value equal to the year 
2008.   
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Table 4. CPI-M Base Year Conversion Factors (bls.gov). 
 
 The base year conversion index was built by dividing the CPI-M inflation factor 
obtained from the Bureau of Labor Statistics for 1999 through 2007 by the inflation 
factor for 2008.  The BLS set 1984 as a base year equal to 100.  Any increase or decrease 
in prices since 1984 will result in an increase or decrease from this base value of 100.  
For example, in Table 4, the inflation factors for years 1999 and 2008 are 246.5 and 
360.8, respectively.  We use Equation 9 to calculate the conversion factor to normalize 
then year costs to a given base year: 
1 + ((Base Year Index Value – Then Year Index Value) / Then Year Index Value)       (9) 
To clearly demonstrate this formula, Equation 10 calculates the normalization factor for 
1999: 
             1 + ((360.8 – 246.5) / 246.5) = 1.464                              (10) 
Normalization factors allow us to modify costs occurring in years 1999 through 2007 to a 
base year of 2008, as shown in Equation 11: 
                      NDC = WCPIM * DC                           (11) 
Medical CPI Medical CPI Traditional CPI Traditional CPI Medical CPI
Year Index Value Inflation Value Index Value Inflation Value Normalization Factor
1998 238.1 - 162.0 - -
1999 246.5 3.5% 164.7 1.7% 1.464
2000 255.6 3.7% 169.3 2.8% 1.412
2001 267.2 4.5% 175.6 3.7% 1.350
2002 279.8 4.7% 177.7 1.2% 1.289
2003 292.7 4.6% 182.6 2.8% 1.233
2004 303.8 3.8% 186.2 2.0% 1.188
2005 317.0 4.3% 191.7 3.0% 1.138
2006 329.8 4.0% 199.4 4.0% 1.094
2007 343.8 4.2% 203.6 2.1% 1.049
2008 360.8 4.9% 212.5 4.4% 1.000
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where NDC is the normalized direct medical cost, WCPIM is the weighted CPI-M 
normalization factor and DC is the direct cost reported in then year dollars by AF/SG. 
Table 4 and Figure 4 demonstrate the necessity of building a special conversion 
index for medical costs.  The data and figure clearly shows that medical costs rise much 
faster than the traditional CPI index.  Using the traditional CPI index instead of the CPI-
M index would result in underestimating the normalized costs when converting to a 2008 
base year. 
Figure 4. Yearly Comparison of Medical and Traditional CPI 
Inflation (bls.gov). 
 
Now that all costs are in a common base year of 2008 dollars, we can concentrate on 
what portion of the costs are due to occupational illness. 
Mean Attributable Factors. 
According to previous research cited in the literature review, Leigh et al, 
Markowitz et al and Steenland et al developed methodology to determine what portion of 
illnesses can be attributed to occupational exposure.  The attributable factors are specific 
to each type or category of illness.  Leigh determined the mean value of the attributable 
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factor is appropriate to use for occupational illness estimations (Leigh, 2008).  See 
Appendix A-1 for a complete list of all illnesses and mean attributable factors included in 
this project.  Table 5 provides a subset of illnesses as an example.  As shown below, we 
see that 5.5% of Pulmonary Tuberculosis cases may be the result of occupational 
exposure.  All further occupational illness cost analysis in this thesis is founded upon the 
mean attributable factors developed by previous researchers.  
Table 5. Abbreviated List of Illnesses, ICD Codes and 
Attributable Factors. 
 
 With mean attributable factors, we can estimate the portion of normalized direct 
medical costs resulting from occupational illness, as shown in Equation 12: 
           NOIDC = MAF * NDC       (12) 
where NOIDC is the normalized occupational illness direct cost, MAF is the mean 
attributable factor, and NDC is the normalized direct cost calculated in Equation 11.  For 
example, if there was $10,000 spent on care for Chronic Bronchitis in 2008, we can 
multiply the cost by the mean attributable factor for Chronic Bronchitis, 15% as shown in 
Illness ICD-9
Mean 
Attributable 
Factor
Pulmonary Tuberculosis 011 5.5%
Lymphoid leukemia 204 1.8%
Parkinson's disease 332 2.0%
Hypertensive heart disease 402 7.5%
Chronic bronchitis 491 15%
Asthma 493 16%
Chronic hepatitis 571.4 0.8%
Chronic renal failure 585 11.4%
Mesothelioma NA 100.0%
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Table 5.  The result is $1,500, which is the portion of medical costs for Chronic 
Bronchitis theoretically resulting from occupational illness.  Mean attributable factors are 
a critical component in the conversion of direct medical costs to occupational illness 
costs.  The factors also apply to bed days and illness frequencies, as shown next. 
 Inpatient Versus Outpatient Medical Costs 
The preceding methodology allows us to develop direct medical costs resulting 
from occupational illness.  The available data also shows inpatient costs and ambulatory 
costs.  Inpatient costs are the result of admittance to a medical treatment facility and will 
result in some number of bed days for a particular stay.  Inpatient cases will be used to 
validate the hospitalization cost factor shown in DoDI 6055.07. 
On the other hand, ambulatory medical costs result from an illness that may not 
be severe enough to admit the patient, such as a routine doctor appointment or “sick call”.  
Ambulatory medical costs will be used to validate the no lost time cost factor shown in 
DoDI 6055.07.  Ambulatory costs do not result in bed days.  However, the data provided 
by AF/SG shows the frequency of each visit for the list of occupational illnesses shown 
in A-1 of the appendix. 
The number of bed days and frequency of ambulatory visits will also be 
multiplied by the mean attributable factors.  This step is necessary to properly analyze the 
modified direct cost of occupational illness with the resulting bed days or visits to a 
hospital. 
No Lost Time Factor Validation 
 To validate the DoD cost factor for no lost time, we will perform a simple linear 
regression.  We will regress the normalized occupational illness direct medical cost from 
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Equation 12 against the frequency of visits due to occupational illness.  We will then 
compare the β1 coefficient from the regression with the DoD cost factor to determine if 
there is a statistically significant difference between the two estimates, as shown below in 
Equation 13: 
   NOIDC = β0 + β1FOI                   (13) 
where NOIDC is the occupational illness direct cost from Equation 12, FOI is the 
frequency of illness visits due to occupational illness, and β1 serves as the validation cost 
factor to compare with existing DoD information. The cost factors provided by DoD are 
20 years old.  As such, we will apply normalization factors using the same procedure 
discussed earlier to normalize the factors to a base year of 2008.   
 Modeling Indirect Costs of Occupational Illness. 
 Indirect costs may be modeled based on hospitalization medical costs and the 
DoD cost factor for hospitalization.  According to DoDI 6055.07, the hospitalization 
factor represents total cost of illness.  Remember from Equation 8 that total costs equal 
direct costs plus indirect costs.  The factor developed in 1988 was $466 per day for 
enlisted and commissioned personnel.  We will estimate the indirect portion using actual 
medical costs, bed days, and mean attributable factors.   Equation 14 shows how indirect 
costs will be calculated: 
               OIIC = (BDOI * HCF) – NOIDC                                      (14) 
where OIIC is the occupational illness indirect cost, BDOI is the number of bed days for 
a patient due to occupational illness, HCF is the DoD hospitalization cost factor and 
NOIDC is the normalized occupational illness direct cost.  The results for each 
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observation allow us to have an indirect and direct cost value for each incidence of 
occupational illness.  Now we can validate the DoD cost factor for hospitalization. 
Hospitalization Cost Factor Validation 
We must determine if the DoD cost factor is robust enough to capture direct 
medical costs and still have allocation remaining for indirect medical costs.  If the results 
from Equation 14 are largely negative, we may be able to conclude the cost factor is not 
accurate enough to total costs, or even the direct portion of medical costs.    
As shown in the literature review, indirect costs have been estimated to be as high 
as $6 to $53 per dollar of direct cost (WSES.com) or as low as $0.59 per dollar of direct 
cost (Leigh, 1997).  Using Equation 15 we can create a new cost factor with the existing 
DoD cost factor and direct medical cost data.  The new factor will allow us to compare 
the two existing indirect cost estimates and lend validity to one or the other, based on our 
results: 
  OIIC = β0 + β1NOIDC + ε                                             (15) 
where OIIC is the occupational illness indirect cost from Equation 14, NOIDC is the 
direct cost resulting from occupational illness, and β1 serves as our new indirect 
occupational illness cost factor estimate.  The coefficient β1 will represent the dollar 
amount of indirect costs that results from each dollar increase in direct costs.  In the 
following sections, the author will normalize the data and perform the analysis, as well as 
discuss results. 
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IV. Data Analysis 
Cost Comparison Tool 
 The data analysis for the cost comparison tool developed for Hill AFB 
bioenvironmental engineers is fairly straightforward.  The analysis will be based on two 
scenarios the engineers provided as examples of current processes.  The current process 
and results will be discussed and then compared with results obtained from using the new 
tool discussed in Chapter III. 
Current Process 
 Bioenvironmental engineers conduct industrial hygiene visits to certain work 
centers on a recurring basis.  Their job includes ensuring safe work practices are followed 
and ensuring workers are protected from occupational hazards.  The commander directed 
engineers to evaluate one process for each work center while the engineers conduct 
industrial hygiene surveys.  The engineers seek out one process that may be improved 
through a reduction in exposure to a hazard.  The process improvement is typically 
justified by cost savings of time, material, or manpower.  However, if the new process is 
more expensive even though it is safer, the proposal may not get funded. 
 To calculate the costs of existing and proposed processes, engineers developed a 
basic spreadsheet. The spreadsheet tracks expected cost savings and initial capital 
requirements.  Engineers then compare this to the cost of keeping the existing process in 
place.  Table 6 below shows an example of the analysis currently done at Hill AFB.  The 
existing tool is a very simple process that compares costs and expected savings.   
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 Table 6.  Hill AFB Cost Comparison Tool, Example 1. 
 
For example, Table 6 is broken down into three major activities.  The first two activities 
show the current process.  The last activity shows the proposed process.  Many cells of 
the spreadsheet were keyed in manually instead of using basic spreadsheet formulas to 
calculate subtotals.  More manual processes introduce the likelihood of error.  The new 
process is estimated at $1,000,000, while current processes cost $16,960.  The difference 
between the two estimations is $938,040. 
 We suggest a simple solution for this problem.  The engineers should utilize basic 
spreadsheet formulas to subtotal each item, showing all steps of calculations to allow 
outsiders to quickly ascertain the intent of the process.  We also recommend utilizing the 
notes or comments function, allowing the end user to add clarification for each step in the 
Office Workplace Cat:
571 AMXS/MXDPAA A-10 Sheet Metal, Hanger 1 1
Activity
Number Activity PPE Type # In Use
Replacement 
Frequency Per 
Year Unit Cost
Annual PPE 
Cost per Activity
1 Chemical stripping Butyl Ruber Gloves 5 12 12.00$            720$                    
3M Full Face air purifying 15 2 275.00$      8,250$                 
3M Half Face air purifying 5 10 15.00$        750$                    
3M P100 Particulate 15 2 8.00$          240$                    
3M Multi-Gas/P100 5 10 20.00$        1,000$                 
  Current Process Subtotal 10,960$            
Activity
Number Activity Exam Type
Cost per 
Exam
Freq per 
year
Number of 
workers
Annual Exam 
Cost per Shop
1 Chemical stripping Occ Physical 400.00$           1 15 6,000$              
Current Process Subtotal 6,000$              
Current Process Total 16,960$            
    
Activity
Number Activity Engineering Control
Estimated
Cost
Total Estimated 
Engineering 
Cost
1 Chemical stripping CNC Process 1,000,000.00$    1,000,000$       
New Process Total 1,000,000$       
Projected 
Savings/Loss ($983,040)
46 
 
cost/benefit analysis.  Documentation is absolutely critical to ensure the analysis is done 
properly. 
 Whatever spreadsheet capabilities are employed to calculate costs and benefits, it 
seems inappropriate to compare the initial cost of a new process with the annual cost of 
the existing process.  As shown, in Table 6, the cost of a new process is $1,000,000.  We 
do not know if this is a onetime cost or a recurring cost.  This information is critical to 
properly compare the new process with the current process, and could greatly influence 
the answer.  Also, other options may be available with lower initial costs but higher 
recurring costs.  We showed in Chapter III how a higher initial cost could ultimately be 
the cheaper option, based on the projected lifespan and other factors.  Next, we will see 
how using a simple model and inputs for initial and recurring cost can make a 
cost/benefit analysis simple, effective, and very transparent for the decision maker. 
Validating Cost Comparison Tool 
 The following sections attempt to validate the new cost comparison tool 
demonstrated in the Methodology section by using it to analyze the analyses submitted by 
Hill AFB engineers.  We start with validating the results of Table 6, where engineers 
concluded the new process would lead to expected losses of $983,040.  Figure 5 below 
shows the new cost comparison tool in action, comparing the costs from an equivalent 
annual cost standpoint. 
 
 
 
 
47 
 
Figure 5. Validation of Cost Comparison Tool, Example 1. 
 
 
 
In this case, shown by Figure 5, the current process is cheaper even when the timeline is 
spread out to twenty years.  The extremely high initial cost of the new process prohibits 
justification on a financial consideration alone.  Option 3 is a hypothetical example, 
where the initial cost is half as much as the proposed option, with $10,000 recurring 
costs.  This option is also prohibitively expensive.  While the end results are the same as 
the engineers’ analysis, the true cost differential per year is approximately $77,000 
instead of the flat loss of over $980,000 reported earlier.  The breakeven analysis fails to 
Life Span (years) 20 Best Choice Option 1
Initial Cost -$                Initial Cost 1,000,000.00$ Initial Cost 500,000.00$   Option 1 versus Option 2 ####### years
Recurring Cost 16,960.00$    Recurring Cost -$                   Recurring Cost 10,000.00$     Option 2 versus Option 3 ####### years
EAC 16,960.00$    EAC 94,392.93$       EAC 57,196.46$     Option 1 versus Option 3 ####### years
Option 1 Option 2 Option 3
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return a useful point of intersect, showing “###” because the annual costs never cross 
each other.  Option 1 is always better than the others, within a realistic timeline. 
 The example in Table 7 shows another analysis conducted by Hill AFB engineers. 
Table 7. Hill AFB Cost Comparison Tool, Example 2.  
 
As we see in Table 7, the new process is estimated to be $13,750.00 more expensive than 
the current process.   The upfront cost of the new equipment is compared directly with 
the ongoing cost of personal protective equipment and occupational physicals.  This 
proposal is much more appropriate to compare as equivalent annual costs due to the 
higher fidelity and lower magnitude of the new process and its estimated costs.   
 Figure 6 clearly shows that although the current process is cheaper in the first year 
due to capital investment requirements, the new process becomes the best alternative 
financially as the initial investment is spread out over a realistic timeline.  In this case, we 
chose 10 years for the lifespan of the equipment.  Of course, actual timelines for 
equipment vary with use and care. 
 
 
 
Activity
Number Activity PPE Type
# used
per year Unit Cost PPE Type PPE Type
Annual PPE 
Cost per Activity
2 noise/mechanical Ear Plugs Disposable 500 0.50$            250.00$               
Current Process Subtotal 250.00$            
Activity
Number Activity Exam Type
Cost per 
Exam
Freq per 
year
Number of 
workers
Annual Exam 
Cost per Shop
2 noise/mechanical Occ Physical 400.00$           1 15 6,000.00$         
Current Process Subtotal 6,000.00$         
    Current Process Total 6,250.00$         
Activity
Number Activity Engineering Control
Estimated
Cost
2 pneumatic tools Noise suppression device for air tools 10,000.00$          
mech work Rubber Isolation mounts 5,000.00$         
Isolation barriers 5,000.00$         
New Process Total 20,000.00$       
Projected 
Savings/Loss ($13,750.00)
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Figure 6. Validation of Cost Comparison Tool, Example 2. 
 
 
 
Figure 6 shows that the proposed option is clearly cheaper than the current process after 
3.7 years.  As long as the new equipment is expected to last 3.7 years or longer, the new 
process should be chosen over the existing process.  This decision is purely financially 
driven, and the author acknowledges there may be other factors in the decision process.  
Option 3 is hypothetical, with half the required investment of Option 2 and half the 
required recurring costs of Option 1.  This option is also financially better after 3.7 years. 
Life Span (years) 10 Best Choice Option 2
Initial Cost -$                Initial Cost 20,000.00$  Initial Cost 10,000.00$  Option 1 versus Option 2 3.7 years
Recurring Cost 6,250.00$      Recurring Cost -$              Recurring Cost 3,125.00$    Option 2 versus Option 3 3.7 years
EAC 6,250.00$      EAC 2,847.55$    EAC 4,548.78$    Option 1 versus Option 3 3.7 years
Option 1 Option 2 Option 3
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Breakeven Analysis
$-
$1,000.00 
$2,000.00 
$3,000.00 
$4,000.00 
$5,000.00 
$6,000.00 
$7,000.00 
$6,250.00 
$2,847.55 
$4,548.78 
Equivalent A
nnual Cost
EAC Comparison
Option 1
Option 2
Option 3
$-
$5,000.00 
$10,000.00 
$15,000.00 
$20,000.00 
$25,000.00 
0 2 4 6 8 10 12 14 16 18 20
Equivalent A
nnual Cost
Years of Comparison
Breakeven Analysis
Option 1
Option 2
Option 3
50 
 
 Based on the two examples provided by Hill AFB engineers, we feel the proposed 
cost comparison tool, emphasizing equivalent annual cost and breakeven comparison, 
offers a much better analysis than the simple manual entry spreadsheet currently in use.  
We now direct our efforts to the DoD cost factor validation.  
No Lost Time Cost Factor 
To begin the data analysis, we will focus on the no lost time cost factor provided 
by the DoD in 1988.  The no lost time factor represents the expected cost per occurrence 
of occupational illness.  The cost factor was originally $120 per day in 1988.  We can 
easily adjust the factor to take into account normal cost growth for medical services, just 
as we did for the direct medical costs in Equation 9 from Ch III.  Equation 16 shows the 
calculation: 
   $120 * (1 + (360.8 – 134.4) / 134.4) = $322.14                       (16) 
where $120 is the cost factor in 1988, 360.8 is the CPI-M index value for 2008, and 134.4 
is the CPI-M index value for 1988.  From this calculation, we show that the DoD cost 
factor is $322.14 when normalized to the year 2008.  This normalized cost factor will be 
used throughout the data analysis for no lost time cases.   
 Military Care and Purchased Care Results 
 Now that the factor has been normalized, we will regress the number of 
occupational illnesses on the normalized occupational illness costs for ambulatory cases 
from FY1999 through FY2008.  The resulting β1 coefficient from the regression can then 
be compared to the normalized DoD cost factor.  As noted in Equation 13, our regression 
equation is NOIDC = β0 + β1FOI + ε, where NOIDC is the normalized occupational 
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illness direct cost and FOI is the frequency of occupational illness.  The author uses JMP 
7.0/8.0 and Stata 10 statistical software throughout the project. 
 As the initial regression results show, the model gives good indication that some 
type of singular cost factor for each occurrence is certainly possible.  The model has an 
adjusted R2 value of 0.887002, which simply means the model explains nearly 89% of all 
variance in the data.  The dependent variable, normalized occupational illness cost, 
displays heteroskedasticity.  Heteroskedasticity means non-constant variance.  We can 
expect non-constant variance with medical costs, because each case will be greatly 
affected by many factors.  Medical procedures for the same type and intensity of illness 
can vary based on where the treatment is provided, the skills and knowledge of the staff, 
and the actions of the patient.  We address the heteroskedasticity and other diagnostics 
later. 
Figure 7. Regression of Illness Costs on Frequencies, Military 
and Purchased Care.
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The outliers shaded in dark gray are all due to Tinnitus cases all within the same year.  
The twelve data points fall outside the general linear relationship.  Based on the hundreds 
of cases of Tinnitus and hearing loss in the data, we assume these cases do not represent 
relative cost/frequency ratio reliability that is shown by the rest of the model.  However, 
we have inadequate case-level information that could justify excluding the cases.  As 
such, we leave the outliers in place and note their existence in the regression.  Table 8 
shows the parametric estimates for the regression plot in Figure 7. 
Table 8.  Illness Costs/Frequencies, Military and Purchased 
Care. 
 
The results allow us to directly compare the DoD cost factor of $322.14 with the new 
cost factor based on actual medical cost data across 71,872 observations.  The resulting 
regression coefficient of $235.58 is much less than $322.14.  Although the t-statistic and 
adjusted R-square results show this model is reliable, we do not yet have enough 
information to invalidate the DoD factor. 
 The medical data contains cases where medical care was provided at a military 
treatment facility as well as purchased from non-military treatment facilities.  Now, we 
will determine if there are any differences in the cost factor based on where the care was 
provided.  We perform similar regressions grouping cases by whether or not the care was 
provided by a military facility.   
Adjusted R square = 0.887 N = 71,872
Variable Estimate Standard Error T Ratio Probability
Intercept -26.87 14.32 -1.88 0.0606
Frequency of Occ Illness 235.58 0.31 751.11 0.0000
Equation:  NOIC = β0 + β1 FOI
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Military Care Results 
 We can quickly manipulate the data to exclude observations where costs were 
incurred at non-military treatment facilities and regress the remaining 42,651 
observations in the same manner as before.  As shown in Figure 8, the results are largely 
similar, to include the outlying Tinnitus cases noted earlier.   
Figure 8.  Regression of Illness Costs on Illness Frequencies, 
Military Care. 
 
Table 9 below also shows promising results for the model.  While the new cost factor is 
slightly higher than the previous cost factor, it is still below the DoD cost factor of 
$322.14. 
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Table 9.  Parametric Estimates: Illness Costs on Illness 
Frequencies, Military Care. 
 
The intercept and frequency are both statistically significant, as shown by the high t-stats.  
One might argue for forcing the regression through the origin, because with no illness, 
there should be no cost.  However, there will always be some cost of healthcare, with or 
without patients.  Also, the variable is statistically significant, so we will leave it in place.  
Now, we will perform similar actions with only the observations resulting from 
purchased care to see if there is much difference. 
Purchased Care Results 
 The results of observations where medical costs were incurred from non-military 
treatment facilities differ significantly.  The differences are not evident from the 
regression plot below in Figure 9, as the model clearly demonstrates a similarly linear 
relationship with few outliers. 
 
 
 
 
 
 
 
Adjusted R square = 0.921 N = 42,651
Variable Estimate Standard Error T Ratio Probability
Intercept 258.87 19.78 13.09 <0.0001
Frequency of Occ Illness 251.59 0.36 705.63 0.0000
Equation:  NOIC = β0 + β1 FOI
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Figure 9.  Regression of Illness Costs on Illness Frequencies, 
Purchased Care. 
 
In this case, the outliers had no discernable pattern of illness or other factors.  Some 
people’s care will obviously cost more than others.  Such is the dilemma of analyzing 
medical cost data. 
Table 10 shows the parametric results for the regression of purchased care and 
frequencies of occupational illness.  Note the much lower cost factor of $115.47 
compared to the normalized DoD cost factor of $322.14.  Also, this factor is much lower 
than the direct care costs incurred at a military treatment facility.  There is strong 
explanation of variance, with an adjusted R-square value of 0.89 across 28,843 
observations. 
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Table 10.  Parametric Estimates: Illness Costs on Illness 
Frequencies, Purchased Care. 
 
 The previous regressions show a wide range of cost factors compared with the 
established DoD cost factor for no lost time.  It may be of little use to develop a cost 
factor for each demographic group and illness.  The results would be cumbersome and 
would likely not be used for rough order of magnitude (ROM) estimates.  However, if we 
can show the existing cost factor is accurate across 74 specific illnesses, we feel the 
combined factor will be more useful for medical cost estimations.  If we find the existing 
DoD cost factor is inaccurate, we will propose an updated factor for DoD to take under 
consideration. 
Cost Factor Comparison 
 Table 11 recaps the cost factors to this point.  We will compare the resulting 
factors in order to recommend the best factor for the DoD to use when estimating medical 
costs of occupational illness resulting in no lost time. 
Table 11.  Costs Factor Comparison. 
 
Adjusted R square = 0.890 N = 28,843
Variable Estimate Standard Error T Ratio Probability
Intercept -9.70 6.05 -1.60 0.1089
Frequency of Occ Illness 115.47 0.24 483.21 0.0000
Equation:  NOIC = β0 + β1 FOI
Cost Factor Value Intercept Adjusted R Square
DoD $322.14 NA NA
Military and Purchased Care $235.58 -26.87 0.887
Military Care $251.59 258.87 0.921
Purchased Care $115.47 -9.70 0.890
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Table 11 shows that all three models developed in this project have high explanation of 
variance, as noted by the adjusted R-square values.  The combined military and 
purchased care regression resulted in a statistically insignificant intercept.  Also, the 
frequency of military care versus purchased care is approximately 2 to 1, meaning active 
duty members are twice as likely to receive care at a military treatment facility as at a 
civilian treatment facility. 
 The likelihood of direct care or purchased care may also have much to do with 
geographical location and type of illness.  Some military treatment facilities have been 
closed, outsourcing most or all care to the local community.  For example, the Air Force 
Academy recently closed emergency services and inpatient services, forcing patients to 
go downtown for care (Press, 2008).  Some military treatment facilities do not have the 
specialty care necessary in some instances, and refer patients off base for specialized 
care.  Again, the Air Force Academy can be used as an anecdotal example based on the 
author’s personal experience. 
 The combined military and purchased care factor is $235.58 per day, with an 
extremely tight confidence interval.  Based on the standard error of 0.31 obtained in the 
regression, the 95% confidence interval is $234.97 to $236.20.  Once we determine the 
confidence interval, we can properly compare the new factor with the existing DoD 
factor.  If the DoD factor falls outside this confidence interval, we conclude that the DoD 
factor is statistically significantly different. Of course, it is obvious $322.14 does not fall 
between $234.97 and $236.20, so we conclude the DoD cost factor overestimates the 
direct medical cost of ambulatory visits based on our data set of over 71,000 observations 
across all ranks, genders, and age groups for the last 10 years.  We further conclude the 
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DoD should adopt a new cost factor of $235.58, rounded up to $236 for ease of 
calculations, for no lost time medical cost estimation. 
 Now that we have decided on a final model, we will run two regression diagnostic 
tests.  The first test will determine the normality of the dependent variable, normalized 
occupational illness cost.  The second test will check for heteroskedasticity. 
 Normality checks for a data set of 70,000 plus observations are challenging.  
Some statistical software packages and computer systems simply cannot handle the task.  
We used the Shapiro-Wilk test and the histogram function in Stata 10.  Appendix A19 
shows the normality results.  To summarize, the normalized occupational illness costs are 
not from a normal distribution.  This is not surprising considering the data manipulation 
required to get to the values used in the regression.   
 In the heteroskedasticity check, we plotted the residuals against the predicted 
values for the regression equation.  The cone shaped scatter plot in A20 notes moderate 
heteroskedasticity.  To overcome this, we regressed the same equation with robust 
standard errors.  The results of this regression can also be found in A20.  The most 
significant change is to the standard errors.  Otherwise, the cost factor remains 
unchanged. 
Hospitalization Cost Factor 
 Now the research shifts to validate the DoD cost factor for hospitalization.  This 
factor is much more complicated, because it attempts to estimate direct and indirect costs 
that may happen as a result of military or purchased care.   
 Following the same normalization process as Equation 16, the DoD cost factor of 
$466 is normalized to $1,250.99 in 2008 base year dollars.  This normalized cost factor is 
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the estimated cost per bed day for an occupational illness, to include direct and indirect 
costs.  We will refer to this factor as a total cost factor because the total cost of illness 
includes direct and indirect costs.  In order to divide the total cost factor into direct and 
indirect components, we will utilize the medical cost data for hospitalizations for active 
duty Air Force personnel from 1999 to 2008.  The total cost per bed day, normalized to 
2008 dollars, multiplied by the number of bed days will be the total cost of illness.  The 
direct costs from the medical cost data will then be subtracted to leave only those costs 
supposedly due to indirect costs.  The methodology of the calculations was laid out 
earlier in Equation 14. 
 Negative Indirect Costs 
 Preliminary analysis of the hospitalization data revealed a serious problem.  Total 
costs are supposed to encompass direct and indirect costs.  However, based on the 3,983 
observations of inpatient medical expenses from 1999 to 2008, the vast majority of 
reported expenses outstripped the DoD total cost factor estimate.  In other words, the 
DoD “total” cost factor was not high enough to cover the direct medical expenses, let 
alone indirect costs associated with occupational illness.  Table 12 shows the preliminary 
analysis of negative indirect illness costs. 
Table 12.  Percentages of Negative Indirect Illness Costs. 
 
Table 12 clearly demonstrates the vast majority of hospitalizations over the past 
10 years cannot be accurately estimated by the DoD total cost factor.  The DoD total cost 
Total Observations Negative Observations Percentage
Purchased Care 2,346 1,799 76.7%
Military Care 1,637 1,578 96.4%
Total 3,983 3,377 84.8%
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factor seems inaccurate to model the actual medical expenses without having any left 
over to consider true indirect costs such as employee turnover, lower productivity, and 
costs to society in general.   Purchased care costs surpassed the DoD estimates in 1,799 of 
the 2,346 observations, or 76.7% of the time.  Military care costs surpassed the DoD 
estimates in 1,578 of the 1,637 observations, or 96.4% of the time.  This again leads to an 
interesting situation where purchased care seems less expensive than military care.  
Finally, aggregating the data, 3,377 of the 3,983 total observations, or 84.8% of the cases 
were higher than DoD total cost factors would predict.   
DoD Cost Factor Invalidation 
 The DoD total cost factor for hospitalization is supposed to estimate total costs: 
direct medical costs plus some amount of indirect costs.  Existing indirect cost estimates 
range from $0.59 to $53 per dollar of direct cost, as noted in earlier chapters.  While we 
cannot say which end of the spectrum is more appropriate, we can say with certainty that 
the indirect costs are not negative.  The DoD total cost factor is not valid on the basis that 
it does not adequately capture even the direct medical costs of occupational illness.  One 
cannot regress the data as proposed in Equation 15 when the dependent variable is 
predominantly negative. 
Proposed DoD Cost Factor Update 
 Based on the invalid DoD cost factor, we cannot use the existing data to 
determine an occupational illness indirect cost factor.  However, we can update the DoD 
total cost factor for direct medical costs only.  As such, the planning factor for DoD cost 
estimating should be displayed in a manner that analysts fully understand that no indirect 
costs are included in the estimating factor.  To be clear, the DoD total cost factor for 
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hospitalization should be renamed to the DoD direct medical cost factor for 
hospitalization.    
 The process for determining a valid direct medical cost factor is fairly 
straightforward.  In fact, we will follow closely with the methodology used for validating 
the DoD no lost time cost factor.  Instead of using the frequency of occupational illness, 
we will use the bed days resulting from occupational illness.  Otherwise, the steps in both 
analyses are comparable. We will proceed by considering all treatment observations, 
military care and purchased care.  Then, we will separate the two categories to see if there 
is any marked difference.  Finally, we will recommend a new DoD cost factor to estimate 
direct medical expenses.   
Military and Purchased Care 
 We have a total of 3,983 observations of medical costs incurred as the result of 
hospitalization of active duty Air Force members from 1999 to 2008.  The reason for 
hospitalization is due to a primary diagnosis of the illnesses included in Appendix A-1.  
The regression equation is: 
            NOIC = β0 + β1BDOI + ε                                         (17) 
where NOIC is the normalized occupational illness medical cost and BDOI is the number 
of bed days resulting from occupational illness.  The resulting regression scatter plot and 
statistics show the relationship between cost and bed days.  
 
 
 
 
62 
 
Figure 10. Regression of Military and Purchased 
Hospitalization Costs on Bed Days 
 
 Figure 10 shows a simple linear regression of combined military and purchased 
medical care costs on bed days, both attributed to occupational illness.  While both the 
intercept and bed days variables are statistically significant, as shown in Table 13, the 
adjusted R-square of 0.214 does not bode well for the initial model. 
Table 13. Initial Total Cost Factor Validation. 
 
In Table 13, the beta coefficient for bed days due to occupational illness is $1,005.55.  
This tells us that for each additional bed day, the occupational illness cost will increase 
by $1,005.55.  Remember back to our normalized DoD total cost factor of $1,250.99.  
Adjusted R square = 0.214 N = 3,982
Variable Estimate Standard Error T Ratio Probability
Intercept 774.18 33.12 23.37 <0.0001
Bed Days from Occ Illness 1005.55 30.54 32.92 <0.0001
Equation:  NOIC = β0 + β1 BDOI
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The regression results show a factor that is lower by $245.44.  It is tempting to consider 
this difference as the elusive indirect costs we sought earlier, as demonstrated by 
Equation 14.  However, the model is misspecified at this point and any regression results 
at this point would be inaccurate.  Perhaps the bed days do not explain enough of the 
variance in medical costs.  While we do not have individual level data for medical costs, 
we do have some additional demographic indicators.  Next, the model will be augmented 
by more independent variables in an attempt to better explain variance. 
 One approach is to include all possible variables in an equation to see if anything 
is statistically significant.  The so-called “kitchen sink” approach relies on results of 
statistical software versus forethought and theoretical modeling (Wikipedia).  Once all 
variables are included, the model is reduced down to statistically significant variables.  
The problem with this approach is that model misspecification may occur through 
inclusion of irrelevant variables, simply for the sake of including whatever data is 
available.  We feel we should make use of available data, provided the model is grounded 
in theory. 
 The data structure allows us to consider whether certain diseases may behave 
differently in terms of accruing costs.  We are able to aggregate the list found in A1 into 
six broad categories: respiratory diseases, cancer, circulatory diseases, high frequency 
diseases, nervous system diseases, and “other” occupational diseases.  The “other” 
category simply contains illnesses attributable to occupational exposure but not otherwise 
fitting into the other five categories.  It is possible one illness category drastically 
influences the results.  We can run regressions including only a specific category or 
excluding the category.  Additionally, we can break out occurrences into purchased care 
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or military care.  The table in A2 summarizes the regression results from the 
aforementioned possibilities.  Out of the 39 simple linear regressions, only a few 
produced somewhat promising results as noted by the adjusted R-square value.  For 
nearly every category, purchased care resulted in a much lower bed day coefficient, and 
adjusted R-square value as well.  Clearly, these models do not convey the results we 
hoped for, either. 
 Data Appearance 
 Looking at the raw data can provide much useful information.  Consider the 
following figures, showing a three dimensional cube of illness category, occupational 
illness cost, and occupational illness bed days.  Figure 11 shows a “cube” from the 
statistical software package, JMP 8.0.  The figure allows us to quickly determine if there 
are any notable relationships between the major category of illness and cost or bed days.  
If one illness category stands out or does not behave as the others, we may need to 
explain the variation before proceeding.  Figure 11 shows how the categories of illness 
differ in the spread of occupational illness costs. 
Figure 11.  Illness Categories and Cost Scatterplot. 
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As shown above, the distribution and variance of costs differ somewhat between 
categories of illness when military and purchased care observations are combined.  
Nervous system disease appears to have fewer observations than the other categories.  
Otherwise, the categories all follow similar patterns:  many observations clustered in the 
lower cost range, with sporadic outlying observations at extreme cost levels.   
  A similar figure in the appendix, A3, shows a graph for all observations 
substituting bed days for cost.  Graphs A4 through A7 display the same concept but 
breaking out military care and purchased care separately.  Looking at A3 through A7, we 
see the spread of bed days among the categories of illness are similar as well.  One 
notable difference between military care and purchased care is that the costs for 
purchased care seem to be a much tighter distribution at the lower levels than military 
care.  A possible explanation of this stems from the military healthcare billing system.  
As active duty patients are cared for in non-military treatment facilities, the charges for 
the care are mostly predetermined by agreements for care through the Tricare insurance 
program.  Fees for procedures are mostly agreed upon through memorandums of 
understanding, which allow the providers to be in a Tricare network.  The insurance 
billing resembles “flat rate” billing as opposed to what a civilian counterpart would be 
charged for the same visit.  Otherwise, no readily apparent differences exist in the data. 
 ROM Hospitalization Model Specification 
Based on our conclusion that there are no discernible differences between the 
illness categories or source of care, we do not have reason to divide the data or create 
separate cost factors.  We submit the results contained in Table 13 stand as our updated 
DoD Direct Medical Cost Factor.  Admittedly, a single cost factor developed from the 
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limited direct medical cost data available is not optimal.  We provide rationale for the low 
explanation of variance, or low R-square value, obtained in our final model.  The 
variance of occupational illness cost depends on other factors besides bed days; data we 
simply do not have access to in order to refine our model specifications.  The model can 
be used as a heuristic approach in order to gain a rough order of magnitude for direct 
medical costs.  The model is still unable to account for indirect medical costs.  However, 
the existing choices of indirect medical cost factors may still apply.  The decision maker 
must determine which end of the spectrum to use, ranging from $0.59 to $53.00 per 
dollar of direct medical costs.   
Parsimony Versus Specificity 
 One intent of this research project was to provide a clean, versatile cost per bed 
day factor.  The factor should apply across all variables: age, gender, rank, source of 
treatment, disease, and number of bed days.  However, based on the previous heuristic 
modeling approach, such an endeavor to create a single robust cost factor is nearly 
impossible.  We would expect high resistance against a model where we controlled for all 
variables.  The model would not be very useful for rough order of magnitude cost 
estimating, which we believe is the basic intent of the DoD cost factors.   
 Although the following modeling analysis will hardly be convenient as a direct 
medical cost estimation tool, we will use all the data at our disposal and attempt to 
provide a more complete approach.  The final model specification is complex, but so is 
the nature of occupational illness.   We feel costs differ depending on the age of the 
patient.  We feel costs differ based on the specific or general type of disease in question.  
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What this new model loses in convenience, it gains in explaining significantly more of 
the variation of our earlier model. 
 In addition to using demographic variables and specific diseases, we tried using a 
log-level model specification.  Logarithmic transformation of the dependent variable is 
helpful because it can compress the range of costs normally experienced in our data set.  
We also set aside the occupational illness attributable factors to see if normalized cost 
would lead to better results.  Each of these options was used across military care, 
purchased care, and a combination of military and purchased care. Finally, we used major 
disease categories, minor categories, sub minor categories, and specific disease lists.  The 
final model is a result of nearly two hundred iterations before arriving at the optimal 
solution. 
 Equation 18 shows the final model specification, with the regression results 
following.  The full list of diseases included in the disease vector can be found in the 
Appendix, A-8. 
      NOIC = β0 + β1OIBD + β2Age + β3Diseasesi                          (18) 
where NOIC is the normalized occupational illness cost, OIBD is the number of bed days 
resulting from occupational illness, Age is a continuous age variable, and Diseasesi is an 
xi vector of 25 specific illnesses listed in Appendix A-8.  These 25 illnesses were the 
statistically significant illnesses out of a list of over 200. 
 The final model performed well when only military care observations were used.  
This reduced our number of observations from 3,983 to 1,637.  However, the high 
adjusted R-square value of .7080 provides some assurance this was the correct course of 
action.  When purchased care or combined purchased/military care observations were 
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included, the explanation of variance fell by nearly half to .3559 and .3502, respectively.  
As expected, bed days and age were statistically significant, as were the 25 illnesses 
referenced earlier. 
 It is important to consider the results within the proper context.  The list of 
diseases originally requested from AF/SG was based on existing literature regarding 
occupational illness.  The results show that some diseases cost more or less, by a 
statistically significant amount, than others.  We acknowledge our results are based solely 
on the disease set in our database.  It is likely another data set of illnesses would produce 
differing results.  The take-away note here is that illnesses are unique and complex.  
Attempting to model “illness” creates an overly parsimonious model with no true 
estimation validity beyond ease of use, which is a poor measure of effectiveness.  
Regression Diagnostics 
 Throughout the many iterations of the final regression model, we performed basic 
diagnostics.  We focused mainly on normality and heteroskedasticity.  Since we 
attempted to use three different dependent variables over all observations, military care 
observations, and purchased care observations, we have a total of nine combinations to 
check for normality and heteroskedasticity.  Normality checks show if the dependent 
variable comes from a normal distribution.  In all cases, the goodness of fit test rejected 
the null hypothesis that the data comes from a normal distribution.  See the diagnostic 
results in A9 through A17 for specific values.  Our results were especially surprising for 
the logarithmic transformation of costs.  The histogram appears highly normalized for 
each case, although the goodness of fit test still fails. 
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 Heteroskedasticity is non-constant variance, which is a violation of basic ordinary 
least squares (OLS) assumptions.  “Heteroskedasticity does not cause OLS coefficient 
estimates to be biased. However, the variance (and, thus, standard errors) of the 
coefficients tends to be underestimated, inflating t-scores and sometimes making 
insignificant variables appear to be statistically significant (Wikipedia).”  We checked for 
heteroskedasticity by plotting the residuals against the predicted values for each version 
of observation class and dependent variable.  The resulting nine checks for 
heteroskedasticity are also contained in the Appendix in A9 through A17.  The log-
transformed data did not appear heteroskedastic, but the others did. 
 We chose normalized occupational illness cost as our final dependent variable.  
This dependent variable displayed heteroskedasticity.  To overcome this, we used robust 
standard errors.  The coefficients do not change, but the standard errors are compensated 
to account for the bias mentioned earlier.  No variables dropped from our equation when 
computing the robust standard errors.  See Appendix A18 for the updated regression 
estimates.  The model specification remains unchanged and the robust standard errors are 
provided to show we acknowledged and compensated for heteroskedasticity. 
 Now that the data has been analyzed, we continue our discussion of the results 
and provide some recommendations for the decision maker.  We also point out some 
limitations in our research efforts and offer areas of further research.    
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V. Discussion 
Conclusion 
 Given the erratic nature of medical cost inflation, we initially theorized the DoD 
cost factors would have understated the actual costs shown in our data.  However, the 
DoD no lost time factor seems to be overstated by 27% compared to our revised no lost 
time factor.  Also, the DoD hospitalization factor seems to be overstated by 20% 
compared to our revised no lost time factor.  It is possible the CPI-M index does not 
apply accurately to military treatment costs as it does to purchased treatment costs.  Also, 
the lack of continuity within DoD hampers our understanding of how the original cost 
factors were developed.  It would greatly enhance our analysis if we knew the factors, 
data, steps, theories, and logic used in the creation of those factors.   
As we conclude this research endeavor, we must discuss limitations, 
recommendations, and further research.  Limitations include data collection problems, 
understanding causes and courses of treatment for illnesses, and organizational 
challenges. We recommend the use of our tools and factors developed within this 
research effort.  Finally, we provide several recommendations of future research 
opportunities, both to add to the progress made here and to break into new areas of 
concentration.  First, consider the limitations we faced in this project. 
Limitations 
 
 Any research project is sure to bring about a number of limitations. This project is 
no exception.  There are issues with data, timeframes, responsibility, oversight, 
communication, privacy, and the inherent complex nature of occupational illnesses.  
While each of these limitations causes considerable problems on its own, the culmination 
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of limitations imposes a substantial challenge to adequately analyzing and modeling 
illness costs in the Air Force. 
 Data Limitations 
Data availability is extremely limited when researching occupational illness.  The 
civilian sector has mandated reporting of occupational injuries and illnesses to the 
Department of Labor (DoL).  The Bureau of Labor Statistics (BLS) then makes the 
highly detailed data available via the internet.  However, federal agencies are not required 
to submit injury and illness data to the DoL.  DoD civilian employee data is eventually 
rolled up and reported to BLS, but the aggregated numbers do not differentiate between 
illness and injury.  Private sector data is presented in great detail, providing specific case 
rates and occurrences for most injuries or illnesses.  With a few clicks, one is able to 
obtain days away from work, rates of illness incidence, fatalities, and much more for a 
wide range of occupations in the U.S (bls.gov). 
Illness data for Active Duty Air Force personnel is a little tougher to obtain.   
The Defense Medical Epidemiology Database (DMED) provides case rates and 
occurrences of any injury or illness associated with an ICD-9 code.  However, there is no 
way to confirm whether the injury or illness was a result of occupational exposure.  To 
overcome this problem, researchers have developed attributable factors to determine what 
percent of a particular illness would likely be caused by occupational illness.  However, 
the incidence rates of the most costly illnesses (cancers, respiratory diseases, etc) are 
extremely low.  These categories of occupational illnesses usually manifest themselves 
decades after exposure.  Relatively speaking, the short twenty-year tenure of a full-career 
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Air Force member does not provide the length of observation needed to capture a large 
portion of most occupational illnesses, especially the most expensive ones. 
In addition to the illness data challenges for Air Force military and civilian 
employees, there are problems with obtaining the actual direct cost data for medical 
expenses.  Actual expenses are tied to actual cases.  It is difficult to obtain costs for an 
illness without accessing databases containing personal information on patients.  
Thankfully for patients, but unfortunately for researchers, cost information is extremely 
difficult to get.  Institutional Review Board (IRB) protocols must be established to ensure 
proper use and disposition of any medical information, even though the cost information 
by itself is non-identifying.   
Illness Timelines 
Timeframes associated with occupational illness were touched on briefly, but 
warrant further discussion.  Occupational illness can be very small and simple, such as a 
case of contact dermatitis caused by repeated exposure to a paint thinner solution.  
Illnesses can also be very large and complex, such as mesothelioma caused by inhalation 
of dust in an asbestos tile factory.  Or, consider a case where a bartender is exposed to 
second hand smoke for years and develops lung cancer.  Determining the exact cause, 
time, and place someone became ill is not easy.  Many illnesses occur years, even 
decades, after a person is exposed to a chemical, dust, fumes, et cetera.  Illnesses can be a 
result of many variables: exposure, genetic propensity for illness, health, diet, and 
diligence in adhering to safe work practices, just to name a few.  The expansive spectrum 
of possible factors plays a major role in how long it takes a person to develop an 
occupational illness. 
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Organizational Challenges 
Responsibility, oversight, and communication are related concerns or barriers to 
effective occupational illness analysis.  Short personnel tenures and even shorter budget 
cycles do not promote long-term planning and intervention policies, particularly at the 
unit level.  Funding for occupational health initiatives usually comes from the Operations 
and Maintenance (O&M) budget.  Some costs (direct medical expenses) for occupational 
illnesses come from Defense Health Program (DHP) money, a completely separate “pot 
of money” within the DoD.  Other direct medical costs are recouped from unit funds, 
such as when civilian workers file a worker’s compensation claim as a result of 
workplace illness or injury.  Disability payments from more serious illnesses come from 
the Department of Veteran Affairs (VA), yet another appropriation outside the DoD.  
Commanders are duly concerned about the health and welfare of the workforce.  Even so, 
there are very few tangible benefits to investing resources in occupational health beyond 
basic regulatory requirements. 
Indirect costs and benefits may be more interesting to commanders as long as we 
can properly quantify them.  Productivity, morale, and turnover all impact the mission.  
As noted in previous sections, turnover costs for civilians are absorbed at local levels.  
Turnover/training costs for military personnel occur at differing levels of Air Force 
appropriations or commands, such as the Personnel and O&M appropriations within the 
Air Education and Training Command.  Productivity and morale impact the mission, but 
are generally unquantifiable as a service-wide application.  Productivity for a fighter unit 
is likely to differ significantly from productivity at a maintenance unit.  Services 
squadrons throughout the Air Force may have differing measures of productivity than a 
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Contracting squadron.  Associating costs to loss of productivity would have to occur at a 
local level, negating the ability to roll up costs into a broader model.  Finally, morale 
would need to be measured through individual surveys over time.  Evaluating morale and 
assigning indirect costs is complex enough to be a research project of its own.   
Illness Cost Profiles 
 Illnesses follow general profiles for course of treatment, depending on the type of 
illness and patient demographics (McCoy, 2008).  Differing courses of treatment lead to 
unique cost profiles.  For instance, a cancer patient may become hospitalized and receive 
chemotherapy sessions at predetermined times during the hospitalization.  Occupational 
illness costs incurred due to cancer in this instance would be fairly consistent, on average, 
across the hospitalization.  Some bed days would result in low costs from observation and 
basic sustenance.  Other days would result in much higher costs from the chemotherapy.  
Trauma patients normally have high initial costs from surgery or emergency care.  
Follow-on bed days for observation and recuperation may result in fewer costs per bed 
day.   
 Illness cost profiles also change depending on when the illness is discovered and 
treated.  The later the illness is discovered, the more costly the intervention becomes 
(Ibid).  For this reason, it may not be realistic to model each illness specifically.  Based 
on the available data, cancer is generally more expensive per bed day than tinnitus.  
However, there are cases where tinnitus is more expensive per bed day, likely due to the 
severity and timeframe of onset to treatment.  Yet, total costs of cancer may be higher 
based on the length of treatment. 
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 Courses of treatment for similar diseases may differ, based on the protocol of the 
treatment facility, access to equipment and skilled personnel, and differing costs of 
medical care across the country.  In fact, the cost of health care can drastically change the 
interpretation of medical cost data.  Dr. J. Paul Leigh excluded two high-cost markets; 
specifically, he excluded California and New York (Leigh, 1992).  Including these much 
higher-priced markets may skew the results and can certainly affect a cost per illness or 
cost per bed day factor.  Our data set did not indicate the geographic location of costs 
incurred.  Some graphic examples of how costs may be incurred for various diseases 
across a timeframe are shown in Figure 12 below.  The data used is arbitrary and is only 
for the purpose of demonstrating how illness profiles may affect cost (McCoy, 2008).  As 
we discussed earlier, costs may occur at different times during a hospitalization 
depending on the injury/illness, course of treatment, and severity of injury/illness. 
Figure 12. Injury/Illness Cost Profile Examples. 
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Note in the above figure, severe traumatic injury costs per day are very high, but 
gradually get lower as the patient may stabilize and move into recovery/observation.  
Cancer costs may follow an oscillating wave profile, with higher costs incurred on 
chemotherapy treatment days and recovery/observation on other days.  The onset, type, 
and severity of the cancer may drastically alter the peaks of the costs, again shown in 
Figure 12.   
Recommendations 
 The author makes several recommendations as part of this research effort.  Based 
on the aforementioned results from the cost comparison tool and the regression results, 
75th AMDS personnel should implement the new tool to enhance the effectiveness of 
their occupational health project comparisons.  The engineers should not limit the use of 
the cost comparison tool to industrial hygiene visits.  We recommend the tool be used to 
analyze any significant capital outlay, or when determining which course of action may 
be financially better over various timeframes and costs.  We also recommend avoiding 
manual data entry into spreadsheets whenever possible.  Formulas provide transparency 
and validity to spreadsheets by allowing analysts to see exactly how the calculations are 
being made.  Notes/comments should also be used to provide more continuity. 
 Additional recommendations involve the data collection, reporting, and analysis 
of occupational illness of active duty Air Force members.  Data repositories should be 
integrated to allow easier comparison of direct medical costs with occupational illness 
occurrence.  Services should also seek to capture occupational illness-related disability 
payments made by other agencies, such as the VA.  Although the costs do not impact 
service budgets, per se, the understanding of the magnitude of costs may influence 
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decision makers when evaluating potential occupational health expenditures.  Ideally, 
analysis at higher federal budgetary levels may result in allowing cross-appropriation 
funding for occupational health projects, with the goal of spending fewer dollars now to 
prevent larger costs in the future.     
 We recommend the Department of Defense adopt our updated cost factors for 
illnesses resulting in no lost time.  We recognize the factors are based solely on Air Force 
data.  However, the fact that the factors have not been updated in 20 years is cause for 
concern, especially if planners are using this information to allot taxpayer dollars for 
medical expenses.   
Further Research 
Opportunities for further research include quantifying an indirect cost, such as 
employee turnover.  We encountered significant challenges linking employee discharge 
with occupational illness.  Modeling one component of indirect costs would greatly 
improve our understanding of the magnitude of total illness costs.  Better communication 
and buy-in with organizations in charge of such data may improve the likelihood of 
future research in this area. 
Other research efforts should be directed at comparing direct medical costs across 
services.  The DoD cost factors may have been built upon data from all services. 
However, lack of information from the DoD prevents us from understanding the 
methodology behind the cost factors.  Accurately planning direct medical costs at DoD 
level requires access to direct medical costs from all services, regardless of who takes on 
the research project to update the factors. 
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Occupational illness is a challenging subject to research.  However, the cost 
savings implications of finding a better way of business provide excellent incentive for 
further study.  To start, successful research requires organizational support and access to 
data.  It also requires an understanding of the importance of occupational illness analysis 
and mitigation beyond dollars and cents.  We applaud those individuals we met during 
this research effort who, on a daily basis, attempt to understand the problems and craft 
solutions for occupational illness issues.
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Appendix 
A1.  List of Occupational Illnesses, ICD-9 Codes, and Attributable Factors. 
 
Illness ICD-9
Mean Attributable 
Factor
Malignant neoplasm of nasopharynx 147 36.0%
Malignant neoplasm of liver/bile ducts 155 0.8%
Malignant neoplasm of nasal cavities 160 39.5%
Malignant neoplasm of larynx 161 10.5%
Malignant neoplasm of trachea/bronchus/lung 162 9.7%
Malignant melanoma of skin 172 3.8%
Malignant neoplasm of bladder 188 11.0%
Malignant neoplasm of kidney 189 1.2%
Lymphoid leukemia 204 1.8%
Myeloid leukemia 205 1.8%
Monocytic leukemia 206 1.8%
Other specified leukemia 207 1.8%
Leukemia of unspecified cell type 208 1.8%
Toxic encephalitis 323.7 2.0%
Other cerebral degenerations 331 2.0%
Parkinson's disease 332 2.0%
Other specified hemiplegia and hemiparesis 349.82 2.0%
Hereditary/idiopathic peripheral neuropathy 356 2.0%
Polyneuropathy due to other toxic agents 357.7 2.0%
Toxic myopathy 359.4 2.0%
Hearing Loss Due to Noise 388.12 100%
Tinnitus  388.3 100%
Tinnitus, no other symptoms 388.30 100%
Subjective Tinnitus 388.31 100%
Objective Tinnitus 388.32 100%
Contact Dermititis and other eczema 692 100%
Bachache, no other symptoms 724.5 100%
Carpal Tunnel Syndrome 354.0 100%
Essential hypertension 401 7.5%
Hypertensive heart disease 402 7.5%
Hypertensive renal disease 403 7.5%
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A1 (Cont.).  List of Occupational Illnesses, ICD-9 Codes, and Attributable Factors. 
 
Illness ICD-9
Mean Attributable 
Factor
Hypertensive heart and renal disease 404 7.5%
Acute myocardial infarction 410 7.5%
Acute/subacute ischemic heart disease 411 7.5%
Old myocardial infarction 412 7.5%
Angina pectoris 413 7.5%
Other forms of chronic ischemic heart disease 414 7.5%
Subarachnoid hemorrhage 430 7.5%
Intracerebral hemorrhage 431 7.5%
Other and unspecified intracranial hemorrhage 432 7.5%
Occlusion and stenosis of precerebral arteries 433 7.5%
Occlusion of cerebral arteries 434 7.5%
Transient cerebral ischemia 435 7.5%
Acute, but ill-defined, cerebrovascular disease 436 7.5%
Other and ill-defined cerebrovascular disease 437 7.5%
Late effects of cerebrovascular disease 438 7.5%
Atherosclerosis 440 7.5%
Bronchitis, not specified as acute or chronic 490 15%
Chronic bronchitis 491 15%
Emphysema 492 15%
Asthma 493 16%
Bronchiectasis 494 15%
Extrinsic allergic alveolitis 495 15%
Chronic airway obstruction, not elsewhere classified 496 15%
Coal workers' pneumoconiosis 500 100%
Asbestosis 501 100%
Pneumoconiosis due to other silica or silicates 502 100%
Pneumoconiosis due to inhalation of other dust 503 100%
Pneumoconiosis due to other inorganic dust 504 100%
Pneumoconiosis, unspecified 505 100%
Respiratory conditions due to chemical fumes and va 506 100%
Pulmonary Tuberculosis 011 5.5%
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A1 (Cont.).  List of Occupational Illnesses, ICD-9 Codes, and Attributable Factors. 
 
  
Illness ICD-9
Mean Attributable 
Factor
Mesothelioma NA 100%
Chronic hepatitis 571.4 0.8%
Cirrhosis of liver without mention of alcohol 571.5 0.8%
Unspecified chronic liver disease 571.9 0.8%
Acute glomerulonephritis 580 11.4%
Nephrotic syndrome 581 11.4%
chronic glomerulonephritis 582 11.4%
Nephritis and nephropathy, unspecified 583 11.4%
Acute renal failure 584 11.4%
Chronic renal failure 585 11.4%
Renal failure, unspecified 586 11.4%
Renal sclerosis, unspecified 587 11.4%
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A2.  Regression Matrix of Hospitalization Cost Factor Model Variations. 
  
Illnesses Bed Day Coefficient Adjusted R-Square Bed Day Coefficient Adjusted R-Square Bed Day Coefficient Adjusted R-Square
All 1,005.55$                      0.214 1,912.28$                      0.568 614.48$                         0.096
Exclude High Frequency 857.43$                         0.127 2,063.84$                      0.460 518.28$                         0.057
Exclude Cancer 978.82$                         0.208 1,821.85$                      0.550 640.78$                         0.103
Exclude Respiratory Disease 1,005.25$                      0.210 1,912.28$                      0.568 587.92$                         0.089
Exclude Circulatory Disease 1,268.72$                      0.421 1,759.86$                      0.629 850.12$                         0.265
Exclude Nervous System Disease 1,001.83$                      0.212 1,907.61$                      0.567 610.07$                         0.095
Exclude Other Illnesses 990.07$                         0.210 1,915.60$                      0.579 603.70$                         0.093
Include Only High Frequency 993.93$                         0.290 1,525.80$                      0.666 549.21$                         0.085
Include Only Cancer 1,241.48$                      0.263 2,443.23$                      0.675 314.16$                         0.028
Include Only Respiratory Disease 1,011.85$                      0.282 875.59$                         0.290 1,268.79$                      0.306
Include Only Circulatory Disease 705.00$                         0.082 3,177.06$                      0.568 477.92$                         0.046
Include Only Nervouse System Disease 1,667.99$                      0.664 2,275.78$                      0.681 1,652.27$                      0.686
Include Only Other Illnesses 1,666.72$                      0.373 1,842.52$                      0.393 1,512.38$                      0.474
All Observations Military Care Purchased Care
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A3.  Scatterplot of All Hospitalizations:  Disease Category and Bed Days 
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A4.  Scatterplot of Military Care Observations:  Disease Category and Illness Cost 
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A5.  Scatterplot of Military Care Observations:  Disease Category and Bed Days 
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A6.  Scatterplot of Purchased Care Observations:  Disease Category/Illness Cost 
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A7.  Scatterplot of Purchased Care Observations:  Disease Category and Bed Days 
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A8.  Final DoD Total Cost Factor Regression Results, Military Care. 
 
  
Variable Estimate Standard Error t-statistic Probability>t
Intercept 90.02 113.76 0.79 0.429
Occ Illness Bed Days 1781.23 40.89 43.57 0.000
Age (Continuous) 8.40 2.87 2.93 0.003
ACT LYM LEUK W/O RMSION 822.11 290.36 2.83 0.005
ACUTE NEPHRITIS NEC 5896.43 813.96 7.24 0.000
ACUTE RENAL FAILURE NOS 306.73 128.78 2.38 0.017
AMI ANTEROLATERAL, INIT 3199.68 575.33 5.56 0.000
AMI INFERIOR WALL, INIT 690.28 200.90 3.44 0.001
ANEURYSM, HEART (WALL) 3639.93 813.04 4.48 0.000
BACKACHE NOS 1616.57 232.15 6.96 0.000
BRONCHITIS NOS -639.05 184.38 -3.47 0.001
CARPAL TUNNEL SYNDROME 3 2965.11 408.42 7.26 0.000
COR ATH ARTRY BYPAS GRFT 2598.04 1151.48 2.26 0.024
CRN ATH NONATLG BLG GRFT 2664.81 1149.48 2.32 0.021
CRNRY ATHRSCL NATVE VSSL 1197.85 97.95 12.23 0.000
DERMATITIS NEC -4878.95 1165.21 -4.19 0.000
EMPHYSEMATOUS BLEB 2440.51 435.97 5.60 0.000
INTRACRANIAL HEMORR NOS 1144.95 436.78 2.62 0.009
MAL NEO ACCESS SINUS NEC 11807.23 1186.30 9.95 0.000
MAL NEO ETHMOIDAL SINUS -5746.27 1171.94 -4.90 0.000
MAL NEO MAXILLARY SINUS 13304.27 1154.85 11.52 0.000
MAL NEO UPPER LOBE LUNG 2508.60 576.17 4.35 0.000
NONRUPT CEREBRAL ANEURYM 1066.29 333.48 3.20 0.001
PULMON TB NOS-MICRO DX -1781.28 669.02 -2.66 0.008
SOLVENT DERMATITIS -3278.66 1172.40 -2.80 0.005
SUBARACHNOID HEMORRHAGE 2 2073.46 335.04 6.19 0.000
SUBENDO INFARCT, INITIAL 654.57 135.90 4.82 0.000
SUBENDO INFARCT, UNSPEC 3354.83 813.44 4.12 0.000
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A9.  Total Inpatient Care Diagnostics, Normalized Cost 
 
Normality 
 
Mean   16435.34 
Std Dev  32756.98 
Std Err Mean  519.03 
Upper 95% Mean 17452.95 
Lower 95% Mean 15417.74 
N   3983 
Goodness-of-Fit Test 
 KSL Test 
D   Prob>D 
0.309055   < 0.0100 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
 
 
 
 
Heteroskedasticity 
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A10.  Total Inpatient Care Diagnostics, Log Normalized Cost 
 
Normality 
 
Mean   3.9461 
Std Dev  0.45883 
Std Err Mean  0.0072 
Upper 95% Mean 3.9604108 
Lower 95% Mean 3.9319033 
N   3983 
Goodness-of-Fit Test 
 KSL Test 
D   Prob>D 
0.032059   < 0.0100 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
 
 
Heteroskedasticity 
 
2 3 4 5 6
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A11.  Total Inpatient Care Diagnostics, Normalized Occupational Illness Cost 
 
Normality 
 
Mean   1267.08 
Std Dev  2103.10 
Std Err Mean  33.32 
Upper 95% Mean 1332.41 
Lower 95% Mean 1201.75 
N   3983 
Goodness-of-Fit Test 
 KSL Test 
D   Prob>D 
0.273964   < 0.0100 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
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A12.  Military Inpatient Care Diagnostics, Normalized Cost 
 
Normality 
 
Mean   18795.48 
Std Dev  31780.82 
Std Err Mean  785.49 
Upper 95% Mean 20336.15 
Lower 95% Mean 17254.81 
N   1637 
Goodness-of-Fit Test 
 Shapiro-Wilk W Test 
W   Prob<W 
0.458134   0.0000 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
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A13.  Military Inpatient Care Diagnostics, Log Normalized Cost 
 
Normality 
 
Mean   4.0225 
Std Dev  0.4280 
Std Err Mean  0.0105 
Upper 95% Mean 4.0432 
Lower 95% Mean 4.0017 
N   1637 
Goodness-of-Fit Test 
Kolmogorov's D 
D   Prob>D 
0.050201   < 0.0100 
Note: Ho = The data is from the LogNormal distribution. Small p-values reject Ho. 
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A14.  Military Inpatient Care Diagnostics, Normalized Occupational Illness Cost 
 
Normality 
 
Mean   1502.42 
Std Dev  2125.34 
Std Err Mean  52.5298 
Upper 95% Mean 1605.45 
Lower 95% Mean 1399.39 
N   1637 
Goodness-of-Fit Test 
 Shapiro-Wilk W Test 
W   Prob<W 
0.557554   0.0000 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
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A15.  Purchased Inpatient Care Diagnostics, Normalized Cost 
 
Normality 
 
Mean   14788.48 
Std Dev  33329.08 
Std Err Mean  688.11 
Upper 95% Mean 16137.85 
Lower 95% Mean 13439.11 
N   2346 
Goodness-of-Fit Test 
 KSL Test 
D   Prob>D 
0.329765   < 0.0100 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
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A16.  Purchased Inpatient Care Diagnostics, Log Normalized Cost 
 
Normality 
 
Mean   3.8928 
Std Dev  0.4719 
Std Err Mean  0.0097 
Upper 95% Mean 3.911983 
Lower 95% Mean 3.873768 
N   2346 
Goodness-of-Fit Test 
 KSL Test 
D   Prob>D 
0.028913   < 0.0100 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
 
 
Heteroskedasticity 
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A17.  Purchased Inpatient Care Diagnostics, Normalized Occupational Illness Cost 
 
Normality 
 
Mean   1102.86 
Std Dev  2072.11 
Std Err Mean  42.780 
Upper 95% Mean 1186.75 
Lower 95% Mean 1018.97 
N   2346 
Goodness-of-Fit Test 
 KSL Test 
D   Prob>D 
0.297847   < 0.0100 
Note: Ho = The data is from the Normal distribution. Small p-values reject Ho. 
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A18.  Parametric Estimates for Military Inpatient Care, Robust Standard Errors. 
Variable     Estimate Std Error LR Chi2              P>Chi2 
Intercept    90.021178 112.78004 0.6370015 0.4248  
Age Continuous   8.398475 2.8431295 8.7026732 0.0032  
ACT LYM LEUK W/O RMSION 822.11306 287.86959 8.135643 0.0043  
ACUTE NEPHRITIS NEC  5896.4303 806.96926 52.538361 <.0001  
ACUTE RENAL FAILURE NOS 306.72886 127.67603 5.7613743 0.0164  
AMI ANTEROLATERAL, INIT 3199.6803 570.38698 31.16971 <.0001  
AMI INFERIOR WALL, INIT  690.28367 199.17353 11.967502 0.0005  
ANEURYSM, HEART (WALL) 3639.9258 806.05927 20.26563 <.0001  
BACKACHE NOS   1616.568 230.1529 48.606181 <.0001  
BRONCHITIS NOS   -639.0501 182.79691 12.176314 0.0005  
CARPAL TUNNEL SYNDROME  2965.1116 404.90901 52.765385 <.0001  
COR ATH ARTRY BYPAS GRFT 2598.0398 1141.5923 5.1711058 0.0230  
CRN ATH NONATLG BLG GRFT 2664.8142 1139.6083 5.4588147 0.0195  
CRNRY ATHRSCL NATVE VSSL 1197.8538 97.113428 145.4816 <.0001  
DERMATITIS NEC   -4878.949 1155.1974 17.741269 <.0001  
EMPHYSEMATOUS BLEB  2440.5126 432.22535 31.575227 <.0001  
INTRACRANIAL HEMORR NOS 1144.9517 433.02879 6.9761387 0.0083  
MAL NEO ACCESS SINUS NEC 11807.233 1176.1067 97.805741 <.0001  
MAL NEO ETHMOIDAL SINUS -5746.275 1161.872 24.279046 <.0001  
MAL NEO MAXILLARY SINUS 13304.272 1144.9287 129.74799 <.0001  
MAL NEO UPPER LOBE LUNG 2508.6021 571.22095 19.173855 <.0001  
CEREBRAL ANEURYM1SM            2066.2866 330.61204 10.36894 0.0013 
PULMON TB NOS-MICRO DX -1781.275 663.2731 7.1965169 0.0073 
SOLVENT DERMATITIS  -3278.658 1162.334 7.9373774 0.0048  
SUBARACHNOID HEMRGE            2073.4588 332.16164 38.510001 <.0001  
SUBENDO INFARCT, INITIAL 654.56833 134.73528 23.433393 <.0001  
SUBENDO INFARCT, UNSPEC 3354.8306 806.45455 17.214558 <.0001  
Occupational Illness Bed Days 1781.2291 40.533946 1275.4918 <.0001  
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A19. No Lost Time Factor, Normality Check Using Shapiro – Wilk Test. 
Shapiro-Wilk W test for normal data 
    Variable                     Obs           W             V                z       
Prob>z 
Norm Occ Illness Cost   71872    0.13775    2.1e+04     27.743  
0.00000 
Ho: Data is from normal distribution. 
 
Based on V coefficient, Ho is rejected.  
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A20.  No Lost Time Factor Heteroskedasticity/Breusch-Pagan Test. 
 
Breusch-Pagan LM statistic:   5087832  Chi-sq( 1)  P-value =      0 
Heteroskedastic Robust Standard Error Results: 
Number of obs =   71872 
F(  1, 71870) =10740.95 
Prob > F      =  0.0000 
R-squared     =  0.8870 
Root MSE      =  3778.8 
 
Variable                            Factor    Std. Err.    T-stat              P>|t       95% Conf Int 
 Norm Occ Illness Cost     235.59        2.27         103.64            0.000       231.13   240.04 
Constant                             -27.18       13.50          -2.01              0.044     -53.64      -.72 
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